<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="6726" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/6726?output=omeka-xml" accessDate="2026-06-07T18:31:32+00:00">
  <fileContainer>
    <file fileId="3783">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/6d5d109f552158de5a99360da32ba4a2.pdf</src>
      <authentication>cbe6f09f352080376a08471f0e47212a</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="104409">
                  <text>HILLSIDE HOSPITAL

FOR PSYCHIATRIC TREATMENT. TRAINING AND RESEARCH

75-59 263RD

GLEN OAKS. N. Y.

STREET

FIELDSTONE

3-7300

JOSEPH S. A. MILLER. M. D.

MAURICE BACHRACH

MEDICAL DIRECTOR

ADMINISTRATOR

SIMON KWALWASSER. M. D.

Assoc.

June 27’ 1955

MEDICAL DIR.

Dear Dr. Fink:
This

is to

I

sure that there

acknowledge,
with thanks, the receipt of $100
for the Research Fund, from
yourself and your Associates,
Hyman Karin and Simon Kwalwasser.
no need

am

for us to

tell

you

is

of the

importance of our research program.
The Directors are appreciative of
the sentiment underlying your gift
of this $100. to Hillside Hospital.
Very

sincerely yours

Maurice Bachrach
MBzhm

cc: Dr. Kwalwasser
Dr. Miller
Mr. Korin

AN AFFILIATE OF FEDERATION OF JEWISH PHILANTHROPIES OF NEW YORK

�June 30, 1955

Somatic Therapy'fbsearch Program 1955-57
From the Research

Service of the Hillside Hospital

mode
of
action
the
to
investigate
A. AIMS: It is the purpose of this study
We
do
by
this
to
plan
mental
illness.
of somatic therapies in
and
personality
behavioral
of
physiological,
the systematic investigation

factors which
B.

may

be involved.

mechanism
conc‘eming
the
therapeutic
Although many theories

BACKGROUND:

been
have
they
advanced,
been
have
of the somatic therapies

cannot
validity
their
that
either empirically disproved, or, are so vague

be

and
hypothesis,
meaningful
more
of
a
development
the
More
recently,
tested.
new methods of study have provided the opportunity

ion. In l952,'ﬂeinstein

and Kahn (Amer.

for a fruitful investigat-

Journal Psychiatry l923 22-26) sug-

of
milieu
a
creating
by
improvement
to
gested that the somatic therapies lead
Some
could
of
denial
operate.
anisms
mec
in.which
function
brain
altered

support for this

hypothesis has been found in the

literature. Carter

(Am.

earlier work of Janis,
unpleasant life memories after

the
of
some
confirmed
1953)
has
§5
330,
Psychologist
of
selective
forgetting
there
is
showing that

electroshock.

non—emotional
and
emotional
of
Using tachistoscopic presentation

demonstrated
1953)
hhS,
§5
(Am.
Psychologist
words, Teicher

that

of repression" to emotional stimuli occur in the post-shock

state.

For the past year and a half preliminary studies

"mechanisms

investigating this

done
been
have
hypothesis

at these laboratories at Hillside Hospital.

results to date

striking.

have been

patients were followed.with serial
taneous

tactile

Twenty—four

The

consecutive electroshock

electroencephalograms and amytal, simul-

perceptual and memory

tests.

A

marked

correlation between

�.02.
improvement and

early, persistent

alogram, and in the amytal

tests

was observed.

appear, improvement did not occur.

sistent

and severe changes on the electroenceph-

It is

If

such changes did not

our conclusion that early and per-

sufficient, prepossible to predict

changes in these indices are a necessary, though not

make
These
observations
improvement.
for
it
requisite
the short term response to therapy during the second and third

week of

treat-

ment.
A

report

on

the amytal test results was presented at the recent meet-

ing of the American Psychiatric Association (May 1955) and submitted fer public-

Electroshock
the
At
of
of
meeting
American
Journal
a
Psychiatry.
the
to
ation
Research Association on

May

8th, a report of the changes in

memory and

learn-

This
was
treatment
presented.
electroshock
of
the
course
ing occurring during
he
Award
citation
Association.
the
of
Annual
Prize
awarded
the
was
report

noted the methodology as exemplary, and offering a

fruitful

method of study-

ing electroshock.
Concomitant with these

studies,t7e

have followed

patients

on

insulin

therapy. Recent reports onthe value of prolonged coma as the basis for
improvement (Kwalwasser and Caplan: J. Hillside Hospital l; 1&amp;5, 1952; Revitch,
coma

E.

:

Neurol.
Arch
A.M.A.
Rowsell:
and
195h;
shagass
72,
Quart.
ﬁg;
Psychiat.

and Psychiat. 225 705, l95h; and Yeager
195h)

In one

gt 3;; J.

Nerv.

&amp;

Ment. Dis. llgg h35,

2
the
over
studies
past
in
years.
in our patients
unusual case report the direct relationship between altered brain fun-

have been confirmed

(Delusional
demonstrated
Reduplication
been
has
and
improvement
denial
ction,
of Parts of the Body After Insulin Coma Therapy, J. Hillside Hospital, 1955,

in press).
C.

METHOD:

1.

we

plan to verify and amplify our preliminary observations on

the relation of changes in behavior to altered brain function after
somatic treatment.

�-3”

E.A. and Kahn,

sease,

Am.

electroshock will be given amytal tests (heinstein,
DiBrain
Sodium
In
Organic
Use
Amobarbital
of
Diagnostic

Patients

(a)

3.:

on

J. Psychiatlggf

Test" for Brain Disease:

889—89h, 1953;

Its

Serial Administration of the

"Amytal

Arch
A.M.A.
Value,
and
Prognostic
Diagnostic

and
before
and
electroencephalograms
l95h)
Neurol. and Psychiat. 1;; 217-226,
treatment.
make
be
a
used
to
This
will
data
preat stated intervals during

diction of the short term response to treatment.
(b)

Double simultaneous

tactile perceptual tests will

using threshold electrical stimulation.

be

carried out

Using two Grass Sh-B stimulators,

to
be
his
for
tested
ability
the
will
patient
monitored by an oscillograph,
of
his
body.
different
parts
to
simultaneously
two
stimuli
applied
perceive
shown
to
been
previously
has
stimulation
simultaneous
double
of
technique
hé-SB,
g}
Neurology,
(Fink
function
3},
be a good index of altered brain
at
The

January, 1952).

By

applying this highly refined technique

it is hoped that

elicited.
be
will
patients
tests,

changes in brain function which are not otherwise apparent

will

be

and
amytal
of
electroencephalognmn
the
case
in
tested before and at stated intervals during treatment.

As

2.

Other Physiological procedures will be carried out in con-

junction with the tests above.
(a) Each patient will be given the mecholyl-epinephrine

cribed by Funkenstein and associates
The

results will

(J. Nerv.

(b)

sulin

coma

as des-

Ment. Dis. Egg: h09, Nov. 19h8).

be compared with the work of previous

as with the results of our other physiological

test

investigators as well

tests.

and
electroshock
of
undergoing
Biochemical testing
patients

treatment have been in progress for

some time

in-

in these laboratories.

In this series of patients, estimates of urinary ketosteroid excretionxates
Simultaneously
esexcretion
rate.
be
post-treatment
to
compared
their
will

timates of steroid sulphates; phosphatase; and blood levels of steroid sulphate,

�«hphosphorus, phosphatase and

total alkaloid will

be done.

of
many
that
investigation
3. It has been evident in our preliminary
months.
within
six
treatment
somatic
relapse
the patients tm.t improve after
imp
of
duration
the
to
involved
in
regard
The critical problem of the factors
provement

is also to

be

studied.

One

hypothesis

now

under investigation

is

related to the premorbid personality.
denial"
verbal
of
the
"explicit
characteristics
the
with
patients
Specifically,
Denial
Factors
in
Personality
R.L.:
and
Kahn,
personality (Mainstein, E.A.

that sustained improvement

may be

1953)
March,
1-13,
ﬁg:
Psychiat.

Illness, A.H.A. Arch. Neurol.
more likely to maintain improvement, than patients
&amp;

of

who do

will

be

not have this pre-

morbid personality makeup.

(a)
two

with
interviews
by
personality
of
premorbid
the
Evaluation

close relatives will

airre will

be used to

be made

elicit

dictive value such as need to

for each patient.

A

standardized question-

characterological factors, which
be

at least

may

have

pre-

right, prestige-consciousness, sensitivity

toczﬁticismand compulsive drive.
words:
and
of
pictures
(b) Tachistoscopic presentation

The

threshold

material
be
compared.with
will
illness
to
related
levels of subject matter
characterological
for
be
evaluated
data
This
will
of more indifferent nature.
assessed
be
as
quantwill
in
response
alterations
In
addition,
indications.

itative indices of denial.
(c)

and
be
Rorschach
given
will
and
the
Test
The Thematic Appereeption

evaluated for the

same

factors as the personality interviews.

to
of
response
predictions
material,
the
of
personality
(d)
the basis
of
treatment
the
to
start
Prior
made
at different periods..
treatment will be
1)
those
unthree
to
possibilities:
according
be
classified
patients will
On

and
temporarily;
moderately
or
to
improve
2)
those
likely
to
improve;
likely
3) those

improvement
and
sustained
marked
maintain
to
likely

(for at least

6

�.5.
Prediction will also be

months).

made

during the course of treatment (the

third weekfbr the electroshock patients) taking into account the physiological
At
the
of
factors.
the
premorbid
personality
well
analysis
indices as
as
conclusion of treatment patients will be evaluated for actual immediate response to the treatment. Those

who showed some improvement

ified again according to whether or not improvement will

will then

be

be

class-

sustained.

h. Evaluation of the change in behavior of patients undergoing treatment

will

Such

ratings will be

be made on the

basis of a modification of the

made

independently of

all

Malamud

the other

rating scales.

test results

by a

supervising psychiatrist.
D.

FACILITIES AVAILABLE:

l.

Hillside Hospital is a

200 bed

voluntary hospital

for psychiatric care. All patients subjected to phy—
siological therapies are available for study. Periods of hospitalization.are
2-8 months; and a h-6 week observation period is generally available prior to
the

institution
A

of physical therapy.

Research Service has been established, with a

full

time professional

staff of a Director (neuropsychiatrist); assistant in psychiatry; biochemist
EEG
and
technician
(Ph.D.)
research
and assistant chemist;
neurophysiologist
and secretary. A full time psychologist and two chemists are associated on a
project basis.
Laboratory
a Medcraft D-8,
two

S—hB

8

facilities include:

(a) Electroencephalographic unit with

channel instrument; (b) Neurophysiological laboratory with

Grass stimulators,

Du Mont

# 3&amp;0

R

oscillograph; two synchronized tach-

Biochemical
(0)
laband
equipment;
electronic
auxiliary
projectors
istoscopic
the
followwith
and
of
equipped
1000
with
feet
laboratory
space
square
oratory

ing major items:

Beckman

spectrophotometer,'Warburg respirator, Coleman Spect-

rophotometer, and radioisotope unit following the basic specifications of the
A.E.C.

�2. Personnel:
(a) Dr.

Max

Fink, M.D., Director of Research: After undergrad-

uate studies at the University College of

his

D-A.

New

York University where he received

cunllaude with Honors in Biology in l9h2, he attended the

New

York

University College of Medicine, graduating in 19h5. After a rotating interneship he served in the

U.SL Army, where he

attended the School of Military

Neuropsychiatry.

training

Formal neurologic
York

(19h8-l9h9) and

was

received at Montefiore Hospital in

at Bellevue Hospital

(

l9h9-1951). Formal psychiatric

training received at Bellevue Psychiatric HOSpital (6
Hillside Hospital (1952).
and
During 1951,
again

in 1953,

New

at

months 1950) and then

he was a research fellow of the Nat-

ional Foundation for Infantile Paralysis,

first at

of Medicine and then at Mount Sinai Hospital in

New

New

York University College

York.

Both periods of

study were under the supervision of Dr. Iorris B. Bender.

In 1952 he was certified in Neurology by the Amer. Board of Psychiatry
and Neurology, and was granted complementary
May

certification in Psychiatry in

l95h. Simultaneously he attended and.gsunnﬁndfrom the William Alanson

Institute of Psychoanalysis, Psychiatry
Certificate for Physicians in January 1953.

White

and Psychology, receiving

(b) Dr. Jeseph Jeffe, M.D., Assistant in Psychiatry:

undergraduate studies

at

their

Following

Columbia College (B.A., l9hh), Dr. Jaffe attended the

New

York University College of Medicine, and was granted

was

elected to Alpha

Omega

Alpha.

He was

an interne

his

M.D.

in 19h7.

He

at the Morrisania City

Hospital, and then began three years intensive study at the Bellevue Psychiatric

Hospital. First as a resident in psychiatry, theniizneurology, and he

com»

pleted his studies as a U.S.P.H.3. post-doctoral research fellow under the
supervision of Dr. Morris B. Bender.

�~7—

From 1951

to

1953 he was

in the United States Air Force.

He

graduated from

the School of Aviation Medicine and was Chief Psychiatrist at the Mitchell

Air Force Base Hospital.
Since discharge from the military service he has been in the private

practice of psychiatry.

He

was

certified in psychiatry

by the American Board

of Psychiatry and Neurology in 1953. Since 19h? he has been a candidate in
White
Psyof
Psychoanalysis,
Alanson
Institute
William
the
at
psychoanalysis
in
Research
Assistant
two
and
the
and
for
past
years
Peychology;
chiatry

Neurology at the Mount Sinai Hospital of
(0)

New

York.

Dr. Robert L. Kahn, Fh.D.: Assistant in Neurophysiology:

After graduation from Brooklyn College
Columbia University which was

United States Army.

in l9h0, he started graduate

interrupted

by

work

at

four years of service in the

In the army he went to Clinical Psychology School and

served as psychologist in various hOSpitals within this country and overseas.
On leaving the army he became a Research Psychologist in the Department of
Neurology of the Mount Sinai Hospital in

the supervision of Dr.
time.

To

date,

M. B.

New

York, where he has worked under

Bender and Dr. E. A. Weinstein up to the present

he has been an author of more than twenty

co-author of the monograph.

"Denial of Illness:

ASpects" which was published

in

Symbolic and Physiological

May, 1955.

received his Ph. D. from the

He

publications, and is

New

York University School of Graduate

Arts and Sciences in 1953, and was an instructor of psychology
and Hunter Colleges

sultant to the

New

for
York

at

Brooklyn

For the past two years he has been a con-

years.
State Department of Mental Hygiene and has conducted
two

training programs in several of thé mental hospitals.
(d)
Chemist:

A

Dr. Harry Goldenberg, Ph.D.: Director of Laboratories and Chief

Trethe
of
he
where
was
a
C.C.N.Y.
l9hh,
of
recipient
in
graduate

maine Scholarship and graduated cum laude, Dr. Goldenberg received

his Ph.D. in

�~8l9h9 from the Polytechnic Institute of Brooklyn.
(who-ll?)
Institute
the
Polytechnic
at
biochemistry

He

(1951 to date).' In l9h7-h9

National Institute
U.S.P.H.S. project

he was a Research Fellow

an
been
has
and

in

instructor in

at Brooklyn College
enzymology of the

of Health, and from 1950 to 1952 he was a chemist to a

at

Jewish Hospital of Broeklyn studying enzyme methods in

clinical chemistry.
(e)

Mr. Hyman Korin, Research

Assistant (Psychology): Following four
College of the City of

military service, he matriculated at
and received his B.S. in 19h? and his M.S. in 1950. During

years of

New

York

1951-52 he was

Ph.D.
his
for
and
matriculated
Sinai
Hospital
psychology interns at the
in
Research
Assistant
been
1953
has
he
June
Since
New
York
University.
at
thesis
doctoral
his
completed
and
has
recently
Psychology at Hillside Hospital
Mount

on "The

Effects of Electroshock on Retroactive Inhibaticn."
3. Publications:

Recent publications of the Research Service include:
The Amytal

Test in Patients with Mental Illness,

1955.
3-13,
ii:
Hospital,
Hillside
J.

Electroshock,
in
Improvement
and
to
Memory
Learning
of
in
Changes
Relation

press).

Conf. Neurologica, 1955 (In

Delusional reduplication of Parts of the Body After Insulin

J. Hillside Hospital,

1955

(

Therapy,

In press).

Relation Between Altered Brain Function and Denial
Amer.

Coma

in Electroshock Therapy,

J. Psychiatry (submitted).

Rectification of Nonlinear Beer's

Law

Plots, Anal.

Chem.

gé: 690, l9Sh.

Bioand
Biochem.
Arch
Curves,
Enzyme
Non-Linear
Activity
Rectification on

phys., ﬁg;

288, l95h.

�July 1, 1955
BUDGET

l.

-.

RESEARCH SERVICE,

PERSOM'EL

1955-56
EFF—ES.

Director of Research

15,000

-

BD OF DIRECTORS

15,000

in Psychiatry

7,200

Research Assistant in Neurophys.

7,500

Chief Chemist

8,200

Assistant Chemist

2,800

Research Assistant in Psychology

h,000

h,000

-

Assistant Chemist

h,000

h,000

~

Assistant Chemist

1,800

1,800

-

2,520

960

150

150

3,810

2,1uo

1,670

1,000

200

800

$ 57,980

$20,750

$37,230

Research Assistant

Secretary -

EEG

Technician

2.

EQUIPMENT

3.

CONSUMABLE

)4.

TMWBL-CONFERENCES

TOTAL

SUPPLIES

7,200

7,500

-

8,200

2,800

1,560

��your grant for the biochemm and neuroplvsiologiul
approved. A mpplamuzy grunt request fer $7992.00
apprum!
by the Public Health Serum for the 24—927 pmaeem This may will amt thsalary or Dr. R. him.

6.
grants were

A.

,

3

The ascend

In sdditionk protoccla were submitted thmgh Hr.

medatim.

m

Calm ta

the Hofheimr

�Department of Biochemistry

.................................

RESEARCH PROGRESS REPORT, JULY-AUGUST

A. Major work

Dr. H. Goldenberg

1955

in Progress

1. Determination of Chlorpromazine in Blood and Urine
procedure for the colorimetric estimation of chlorpromazine and related
alkaloids, described in the June 1955 progress report, has been further refined
to permit detection of the extremely small amounts of drug circulating in blood.
The method is based on two new features: (1) The finding that drugs can be
quantitatively extracted from biological fluids with a single portion of an
ethylene dichloride-ether solvent mixture, and (2) The use of a three—phase solvent
dye partition system of analysis.
The

Clinical data are also being obtained on bound as well as free circulating
promazine, based on the use of hot acid to liberate the conjugated drug.
2. Inhibition of Cholinesterase by Hallucinogens
These studies are being continued as indicated

in the prior report.

3. Steroid Sulfate Conjugates
All but one of the major problems involved in the assay of steroid sulfate
metabolism.in mental disease have now been solved. A novel device has been
introduced for eliminating the interference with our test due to phenol sulfates
in blood and urine. A two-phase system incorporating dicyclohexylamine (DCHA) as
a complexing agent effectively separates the steroid from the phenol sulfates,
permitting their unequivocal determination. The procedure for serum is now as
follows:

is treated with alkali to release the hormone conjugates.
b. A lipid solvent is added to precipitate the proteins and simultaneously
extract the hormones.
DCHA
The
and
between
to
brought
is
dryness
supernate
partitioned
c.
lipid
a.

Serum

and chloroform.

free steroid sulfates are released by shaking the chloroform extracts
with acidic resin.
e. Final assay of the sulfate conjugates is effected by adding dye and reading
the color.
d.

The

considerable amount of clinical data have already been obtained on normal
people and on patients selected for independent studies by the Sloan-Kettering
Institute. An immediate correlation has been established in our laboratory
between urinary conjugate levels and sex, males excreting about twice as much
conjugate as females. This ties in well with what is known of steroid metabolism
A

�and tends to confirm the

validity of the method.
Attention is now being devoted to fractionation of the steroid hormones in
conjugate form. Paper electrophoresis has proven inadequate for the purpose.
Paper chromatography is more successful and is under continuing study.
B. Papers, Lectures and Conferences

following papers are in preparation: (1) "Colorimetric Determination of
Alkaloids, with Particular Reference to Chlorpromazine", and (2) "Steroid Sulfate
Conjugates. II. Colorimetric Microestimation".
The

C. Funds and Personnel Changes

1. Research Grant #A-675 from the National Institutes of Health
the fiscal period Sept. 1955 - Aug. 1956.
2. Messrs. Michael Miller and Spencer Parness terminated
in the laboratory at the end of August.

cc. to: Dr. Fink
Dr. Miller

their

was renewed

for

summer employment

�Department of Biochemistry

.................................

RESEARCH PROGRESS REPORTI SEPTEMBER

-

A. Major werk

Dr. H. Goldenberg

12§§

in Progress

1. Determination of Chlorpromazine in Biological Fluids
As a result of repeated analyses of blood drawn from patients receiving
chlorpromazine, the circulating blood level has been established as less than
1 microgram per ml. serum. The three-phase solvent dye partition scheme of
analysis mentioned in the previous report has therefore been adopted as the only
method capable of detecting the extremely minute amounts of drug in peripheral
blood. A new shaking machine has just been obtained from the A.H. Thomas 60.,
Philadelphia, to permit application of the method on a broad scale.
question naturally arises as to the metabolic fate of chlorpromazine
in humans. We have recently detected in patients! urine an ether-soluble carboxylic acid which reacts with ferric chloride and appears to be an oxidative
byhproduct of chlorpromazine metabolism.
The

2. Inhibition of Cholinesterase by Hallucinogens

three-phase system mentioned above has been found applicable to the
analysis of LSD 25 as well as chlorpromazine and serpasil. By combining this
observation with the earlier discovery of the inhibitory effect of LSD 25 on
human serum cholinesterase, it is now possible to relate the enzyme inhibitory
action to the alkaloid concentration in "unknown" samples of fluid and so deter—
mine the specific molar inhibitory action at the 0.1 microgram level. This
amounts, in effectI to the first sensitive chemical test ever reported for the
detection of LSD 25 and related hallucinogens.
The

3. Steroid Sulfate Conjugates
work progressing

cc. to: Dr.

essentially as described in JulyhAugust report.

Fink
Dr. Joe. S.A. Miller
M.

�TJ'M‘

W10,”

kW!“ mmMume

mmﬁmmmam.mu¢wmtbmmmm
dﬁltﬂdmﬁord’pﬁiﬁﬁd‘ﬂ.
7

mauummm

�WW

Wmmtmmmunmmngmpm.
3.)

nmmmm
Wamwmm‘m M.anummt.mk

mmmwmmummmm.w.
mmrpmhmmmmdmdt

“Wumm
Mnuwhmwmmmmmmmunm

�.3.

«W.
wammnwunm-Wmum.
Athd.w.MMmmumngmmu

m ﬂui- num- um‘ «hummus. tad

but

mumummmwmmmmmmmm
mmmmmchob.
mmummmuummmw.
max-m:-

mmmdmwmmmmumm
arm-m
1

'

ranoummwmsmummmmsu

?

memum:mW.mm-n
mmmmupmmmruamrm

_

um

i

M

W’ mWrmmwn-m
A.)

awrmm.hmmmnmwmuuuuu
¥

.

McMrahmmwuﬂaMde-u
Itummumuumt
WWSMMWM
mmwumramn.
mum

women-mm
.thmmmmwmubaummmmpm
‘

‘

3.9

ammmammwmummmmam
Dr.3hu,nhobndhndm
WthathuhtaW.
Manama-.Wumwmmmmmm
’mmmnmmpammmmwwmmmu
thramutmm,mmmmmm-mm
rummsmum. mumnwmmwumm

‘

�.5.

nth-Wm
mmmummmwmwmoamm

mmpummmmrmmuu.

arm-«mmgmnwnmm.

Doughnuts-mam

W
bmmammwmmmmmmw,
«3.6mummam.
M

A.)

mwmmmwmwww

MiamﬁmmuVMWqutmcw

W‘tmhmmwmammmnmm
mmmammunmm‘mmrmunmm
I.) mmmmmmmwmhm¥
[wwlmmumumummummmm
ﬂan

«mama-Wm.
It.)

men-mmnmmwmw
umnwmmmmammmuunmmu
ﬁner-matey». nwmrmxmmmmwu
mmmmmammmmnwnma;mmnw
1.)

WW

mhmummunmm
Mud
1mm
m
Amuse.
“raw
W
0‘an
‘mmmwnmwmmmnbmm.
3.)

Du.'llhn.

mamwmtmpnmmummnmmwm
mm

mum
MWWW
muncd‘tblnnmSwuquMummmedm
mumsmmmuwwmmmwnm m
a.)

�kW3lemwhtb
Mun-dun
mrmmmwdthwmdmmm
A.)

nun-Moth.“
B.)

mammm,ummm
,1

ummumgmumwtummrmum
Mm'wm-mmuwmmmuvmm
wan.

wwwhummrww‘.’
c.)

magnum-1mm «numb-mu;

WuﬂthMWdhu-lmmiuuMN
“Widthmrdummnuuhmmm.
6-)

W
A.)

nan-13mm: ‘MmmMmam

Wmmwumnmammxpwm-w
wuuxabmummeuuumMW.Mumu‘mmmmum.hmc
n.)
hummus-«momma

0on1“...

wmmmwmmmumaAuumamm-w

Wmtquolmy
a.)
my:
Dr.

Project:

mum; our Manon

www.mxmwmawammounmpma.

Thaw

Wuwmawrunnmtmwmmmuw

�m1.4

Magnum-ma.
B.)

Marmara!

W’agmhuuamm

than”.
than:
mWaﬂhMcmﬁu
mummm

WatWMIMﬁummmum-Mamm.mm
www.mmmmrummpumnuua¢
mmacmﬂmﬁnmnﬁurwtm
30mm): Mum

mm. w.

�mm.”

thmx‘mmumummmumumum

thus

of

Dr.

awammmmuummmmmmm
ml
Mull”, t» n:
kin
Win.
www.mrammwwmdmmmm
«lulu-Man,

tho

In

m,ammwmmmmmutbnpmmetam

�4-

nm. www.maruummmmowmwmaotu

“www.mmmmdmpmmpm.
a.) 80mm:

m-pmmtmmummnnh

Wuwmmummmgm
dWﬂMmIﬁnmmmMMltﬂﬁlﬁl. Mamba“
animautthimdatMOmth.

uranium that thin prudential} manna
I.)

u

ammm

Wmduungthowttumthu

emu:- put.
hunma.»
MM:
&amp;

m

bun

Mmenuh-nnnpb

MMNMWWMWwWMIlimIn
1Mrumtothutmtmtm
Mothrpumumbmmwa

twpmmemmmuammmommumm

�¢
ummummmmmuuhgmmn
dam It
All um patient: an amt-ma.
hummmwagwmgmsmmm ﬂux-four

WW.

and

mammuwuumnmmam.
“Mnuummumm. humannhhhobo
wwwmwmmmrmummm
new-cut.
‘

'

’*)"W 3mm amusmmmm

mum,mmurmmwtmm.

“In!!!

Wu:mraummwummdmm
Mechanism-heathen“. thmatmmmmt
m,munumrudumix.

WWW
MMWMWmhbdumtamem
3.)

“than

«ummammec'mumMMta-am
Mahmuqmwktum. nr.8h~.mmmuu

Wdhmwuuwmmumm
mmmmmpmmmmwwmmm

”wrumzmmmmmwmm-mum
{crumbs-Itch mumnmmmwumw

�*,~b.«.4‘

_.x

:a:

h3-memmM1ﬂ-dwuﬂm

matmmmuwMWunmumcc-u

mmdmw-usmmwmmm,nan
Wasmnmmwawmmnwm
mmmmwnwmmmunnmm
mmwmmmwwmhm
a.)

thmuMnmdm.mummm
“mummy-norm.
13-)

,W
1.1

Dummy—unannmwwm

umumnr.m'mnsnmuu¢mumm
nmmmxmmmmwu
Warm
m’mmamm~mmnmmuaww
WWW-t. a.)

mmmdmmm
Wmmumumnn.mnmwwmwmmm

�«5-

muomMqurmtmmau—amw
ﬂawuﬂlm.mrwm
m: A.)
hmnmmmmmwm
muss-dam
mrmmtwmwmmmcm.um
It)

“unmanned”...

mummmgummw
namuuumapmmmmtammrm
mmmmmmma-Wmmwmm
_

n.)

Itmmmmtm'm
ummmmuw.
MmMuWammm-‘Wmmmtcm

com.

mmudmu‘mmrnw.
c.)

mmwzmnr.4omn.mua

”Waumhmmmawmmmmu‘

W

atmuambmmamummm.
a.)

A.)

.

Mata-whom: mambo-ammu-

WmhmﬂWRMEtm-Withmw
mwilmantoDr.Mumm1uw‘hn-ﬂurdw
mauwmummmm:
I.)
~

msmvamotanmnmm:

0min...

“WMMWWMWWNWMMW

erumvalm. Prom Fohovingmdimim
WI
nan-.mmxmngamu-emmampmu Mam
a.) Dr.

mmnuuudatwrmnummmmmhmmm

�mum-mu.

n.)

nun-rum WWII-luminous

mummmnmummmwmm.

mum

Wummmmomumsnnamw-m
www.mum.mmummmma:

’mmuem‘mwmrvwgm

W

m&amp;%

11.:an

.

�\ﬂ
October 20, 1955
MEMORAEDUM

TO:

Dr. Joseph S. A. Miller

mom: Max Fink, 14.1).
SUBJECT:

Six Months Report of Research Activities at Hillside Hospital

At the request of the Chairman of the Medical Affairs Committee,
I am submitting this six month report of the activities of the Research
Service and associated research activities at the hospital. During this
period, numerous projects have been under investigation, our staff has expanded, and our space requirements were met. Two projects are being completed, and one project has just been instituted.
A.

PROGRESS

l.

hmw2:
In

ONGOIﬁG PROJECTS:

ELECT§9§§QQK #

Our second electroshock project was undertaken in March
project had clearly demon-

in September. Our first
strated that cerebral changes were essential to improvement and that these

1955, and completed

could be measured by the electroencephalogram and by amytal tests. 'Ue
also concluded that memory tests were a poor index of improvement and believed that there were specific psychological patterns indicative of denial
which were more prominent in the improved group than in the unimproved.
Following this study, the second project was undertaken and was designed
to demonstrate the reliability of the electroencephalogram and the amytal
tests for prognostic purposes; and to ascertain the characterological as‘ﬂe
term
be
term
the
short
which
and
in
results.
long
factors
might
pects
have studied.twenty-seven patients to date. The data of this project is
now being processed, and will be available following our six month follow
up

period, (which is from November to January).

data from the first study was pres nted at various meetings,
including the American Psychiatric Association, the Electroshock Research
Association, and the Eastern Association of Electroencephalographers. The
memory data, presented by Mr. Korin at the Electroshocx Research Association
The

in

May, was awarded
The

their

annual prize.

electroshock project #

3

is

below), and will be instituted November 15.

now

in the planning stage (see

This project, which has been undertaken with Dr. Sidney Tarachow of
the Medical Board, has accomplished a considerable amount of its basic work.
Three approaches to the problem of measuring ambivalence have been accepted.
These include an interview evaluation; the thematic apperception test, and
tachistoscopic presentation of pictures. During this period of evaluating
methods, twenty-three patients have been studied. Dr. Tarachow has been
attending to this work, and the testing has been undertaken by dr. Korin.

2.

AMBIVALcNCE:
‘

�~2-

Serpasil evaluation study, undertaken at the end of last year, is com~
double
blind
a
by
been
have
studied
intensively
Seventeen
patients
pleted.
Blumberg
Drs.
andeachspress.
evaluated
by
The
now
data
being
is
technique.
To date, the clinical results are disappointing. Patients who were depressed,
who
were over-active
Patients
symptom.
of
this
manifested an eﬁag ration
disturbed/EnogIIeviation
of this activity but the psychotic ideation genand
of
secondary
induced
a
The
variety
intramuscular
dosages
erally persisted.
complaints. In the evaluation of'the mecholyl responses following serpasil,
The
blood
in
pressure response
all
subjects.
effect
consistent
was
a
there
of
this
presentation
considering
Dr.
and
Blumberg
is
lower
was significantly
data at the next meeting of the American Psychosomatic Society.
3.

SQRPASLL:

The

}

Preliminary studies by Dr. Laderman in
20 patients in a series of clinical
not
was
but
significant
this
alterations
and
behavioral
showed
symptom
studies
of
Shaw
evaluation
undertook
an
Dr.
In
mid-September,
in the doses used.
A
protocol
coma
therapy.
Thorazine as a possible substitute for insulin
French
and
Kline
submitted
Smith,
to
was
The
Research
Committee,
approved by
and approved, assuring us of adequate supplies for the duration of our proof
8,to
a
medication
for
period
receive
will
In
this
study,
patients
ject.
12 weeks, comparable to the insulin coma period. During this time, very
have
been
To
be
used.
patients
eight
date,
will
thorazine
of
doses
large
The
obser3600
1500
initial
from
to
The
daily.
mg.
dosages range
studied.
three
had
clinical
response;
a
show
significant
three
the
patients
vations

h.

THORAZINE:

and
one
symptoms,
toxic
developed
one
minimal
had
patient
changes;
patients
medthe
of
Cohen
and
Blumberg
Drs.
medication.
the
patient has just begun
our
using
to
permit
controls
the
have
contributed
necessary
ical department
such large doses of this potent drug.

Since June, Drs. Goldenberg
and Royce have been coopof
a
in
study
Sloan—Kettering
Institute
the
chemists
the
at
with
erating
the possible alteration in the keto-steroid excretion patterns in our patSince
June.
Committee
Research
in
by
our
This
was
approved
study
ients.
then five patients have been under investigation. The initial data is not
in
Dr.
Goldenberg
by
studied
Each
of
being
the
is
patients
available.
yet
his laboratory as well as by the chemists at the Institute.

5.

SLOAN KETTERIDG STUDY:

Dr. Goldenberg has been
occupied in studies measurand
acid
of
devising
the
effects
lysergic
estimating
ing chlorpromazine,
methods to measure steroid sulphate conjugates. This basic research is
to
which
to
we
apply
measurement
plan
of
methods
the
to
provide
necessary
our patients.
(a) Chlorpromazine: An ultra~sensitive technics has been
of
amounts
this drug.
microgram)
minute
(0.1
which
measure
can
developed
Golden—
Dr.
Thorazine,
of
number
By applying this to a
patients receiving
bloodstream.
the
amounts
in
small
appear
demonstrated
only
that
has
very
berg
LSD
has been
by
cholinesterase
The
LSD:
of
serum
(b)
inhibition
A
compounds.
demonstrated, and this test applied to other hallucinogenic
correlation between hallucinogenic activity and cholestestcrase inhibition
was found.

6.

BIOCHEMICAL RESEARCH:

�*3“

a

(c) Steroid Sulphate Conjugates: ‘Nith the grant support from the
USIHS, methods to estimate these compounds have been devised. By studying
hormone
demonstrated
sulphates are synthat
Dr.
Goldenberg
liver slices,
of
the
level
in
difference
and
a
there
sex
is
that
the
thesized by
liver,
steroid excretion. Both these observations are of fundamental significance,
and will be presented to various societies this winter.
In the Department of Medicine, hrs.
Cohen and Blumberg have continued
Durand
the
electroshock
of
the
patients.
serpasil
studies
their Mocholyl
and
than
more
been
have
studied
to
additional
an
patients
this
period
ing
half have had more than one such evaluation. The serpasil group demonstrated
a significant alteration in their blood pressure patterns following this
done
be
and
been
will
has
The
correlated
not
data
electroshock
yet
drug.
as soon .8 our electroshock # 2 data is available.
7.

MECHOLYL:

Following the approval of this project
by the Research Committee last spring,
Drs. Navarre and Graubert had a number of meetings with members of the
Medical Board. Following these discussions, they have begun a pilot study
of one patient, and intend to evaluate those factors in the hospital environment which may be contributory to the patient's improvement. This
satisfactory
pilot study was udertaken in an effort to clarify a protocol
to the Ibsearch Conmittee and of sufficient quality to be submitted for

8.

SUBCULTURE:

To
some extent, this project
outside
to
organizations.
financial support
was hampered by the multiple duties of members of the committee and by
the resignation of Dr. Gurvitz. Since September, however, the committee has
been working very actively and it is anticipated that a satisfactory protocol will be available by the end of the year.

In June, following some
discussions concerning the
Laderman
and
Drs.
coma
of
insulin
doses
for
insulin
treatment,
correct
doses
between
the
multiple
relation
into
undertook
an
Blumberg
investigation
05 insulin and the blood glucose level. lt was anticipated that multiple
small doses of insulin might reduce blood sugar significantly earlier and
large dose. It was quickly determined,
for longer periods than a single
.)
however, that multiple small doses, even if the sum total was equal to a
This
and
of
depth.
coma
degree
a
not
did
satisfactory
produce
dose,
single
project is now being prepared for publication.

9.

B.

DIVERE'

I

SULIN

D

SE8:

PROJECTS PLANI‘IED:

November
#
the
third
Electroshock
3:
Beginning
let,
l.
electroshock project will be
undertaken. This study is designed to extend our experience with the factors
which may be relevant in both the long and short term clinical reSponses
following electroshock. Also, in this study specific emphasis is placed on
the psychiatric and language changes which follow electroshock treatment
and which we have been accustomed to calling "improvement." Dr. Joseph
Jaffe has prepared a number of specific studies, including detailed interviews with patients prior to and during treatment, in which specific aspects
of behavior and language will be assessed.

�a...
In this study, also, a basic problem in the perception of multiple
simultaneous tacti e stimuli will be undertaken. Under our original grant
from the United States Public Health Service, we were given funds to study
the problem of Satisfactorily delivering single and multiple independent
and
The
completed
was
designed
equipment
wave
impulses.
electrical square
in Septemler and for the past few weeks has been undergoing rigorous clindur«
be
and
will
applied
found
been
has
satisfactory
highly
ical tests. It
between
changes
the
of
relation
the
with
question
specific
ing this project
the
in
and
in
behavior,
changes
stimulation
tests
simultaneous
double
in
electroencephalogram and in amytal tests following electroshock.

2.

EIOC

‘thAL

APPLICATION OF

HEM

TESTS:

’

Dr. Golden—
berg has

completed.the pilot studies necessary to devise measures of Specific compounds. He believes these should be applied to our clinical population over
the next year. A specific protocol for this application is being prepared.

3.

For more
than a year,
has been interested in form-

EEQQNOSTIC IdDIGATQE§ﬂIﬂ ELECTROSHOCK:
'

‘

Dr. Karliner of the attending psychiatric staff
electroshock.
would
be
in
which
helpful
factors
some
prognostic
ulating
Discussions were held in June and at the suggestion of Dr. Miller, Dr. Karlbe
This
scale
will
evaluate
scale
to
prognosis.
iner prepared a special
months.
next
the
six
and
Committee
assessed
over
Research
the
to
presented
C.

STAFF CHANGES:

Dr. Joseph daffe, a practicing peychoanalyst, was
and
in
research
psychiatry,
assistant
Service
Research
as
appointed to the
behavioral
the
in
is
Dr.
interest
Jaffe's
work
on
September
began
lst. induced altered brain function and the
by
and language changes which are
relation between such changes and premorbid personality.
were resolved effectively
Lowenstein
of
the
floor
the
on
the
of
first
extension
the
laboratory
by
The
reduced.
been
tachistoscopic
have
also
Our
problems
equipment
building.
be
able
now
to
works
and
well.
are
into
alignment
was
brought
equipment

During

this period our space problem

simultaneously.
two
or
individually
pictures
tachistoscopically
present
The electric stimulatorsale functioning satisfactoraly so that we are now
able to produce isolated simultaneous square wave stimuli with the ability
to vary any of the essential parameters.
D.

FUNDS:

In May, we submitted an application to the United
Sept—
In
of
Dr.
Jaffe's
Service
Health
program.
for
support
Public
States
an
in
the
and
staff
interviewed
the
Frank
Jerome
came
to
hospital
Dr.
ember,
USPHS
the
from
in
we
anticipate a response
evaluation of our program.
mid—December. In June, we also submitted the necessary forms for second
renewals
and
both
and
Dr.
Goldenberg
myself,
both
renewal
for
grants
year
the
these
both
renewals,
note
for
that
to
were approved. It is important
overhead allowances were increased to 15%.
At the suggestion of Mr. Coleman, specific protocols of our re»
search program were submitted to the Kaufman, hoffheimer, and lttleson

Foundations during this period.

�-5the
been
for
has
Service
writing
Research
the
which
The protocol
of
Committee
Research
the
submitted
to
was
Ford Foundation grant pr gram
was
the
protocol
that
the
consensus
was
the Medical Board in September. It
suggestions,
their
Following
be
submitted.
not
and
that it
unsatisfactory
of
Drs.
the
with
cooperation
Service
Research
made
the
by
changes are being
Lenzer and Luttrell.
another
submit
application
to
am
planning
I
present time,
re—
March
for
meetings
their
to the USth in January for consideration at
to
an
application
am
contemplating
also
I
newal of our present program.
ambivalence
study,
the
for
for
Fund
support
for
Psychiatry
Foundation
the
as soon as the basic work is completed.
At the

E.

Q?HER.ACTIJITIES:

l.

ISRAEL 5T3§p?§nF9§E§Ei9F THE JOURNLL QEWEELEEERE
HOSPITAL: Following diScussion with Dr. Tarachow,

the Research Service has undertaken the
Tarachow
issuin
Dr.
work
in
and
ssisting
editorial
necessary secretarial
Journal.
Volume
of
Hillside
the
Commemorative
the
special
ing
2. ISRAEL STRAUSS LECTURE: Consideration is being
given by members of the
at
Discussion
is
next
the
lecture.
Committee
for
Lecture
Strauss
Israel
should
decision
and
a
final
candidates
of
number
present centered about a
be available by the end of November.

Respectfully submitted,
.

i

"’ -,"
’-

4

H7

”.51
‘

‘)

{I

1

«I

g.“

,--‘or

,.

‘

j

.

If

‘f‘ \

Fink, M.D.
Director of Research

Max

.

.

�Department of Biochemistry

.................................

Research Pro ress Re
Major werk

l.

rt,

Dr. H. Goldenberg

November l9§§

in Pregress

Chlorpromazine Studies

previous work has been summarized in the report for the 6 month period
ending Oct. 1955. We have subsequently learned from two representatives of the
Smith, Kline and French Laboratories that Drs. Salzman and Brodie, working at
the National Institutes_of Health, have identified chlorpromazine sulfoxide in
the urine of dogs and men after treatment with chlorpromazine. A sample of the
sulfoxide was requested from Smith, Kline and French and arrived the end of Nov.
Our

ultraviolet absorption spectrum of the sulfoxide was determined in
aqueous solution and compared to the Spectrum obtained with extracts from
patients! urine. A remarkable similarity was noted. On the basis of this and
other data accumulated in our lab., there can be no doubt but that urine from
mental patients receiving chlorpromazine contains: (1) chlorpromazine, (2) the
sulfoxide, (3) one or two other alkaloids of related structure, and (A) at least
one break-down product which yields a violet color with sulfuric acid, as contrasted to the pink colors typical of chlorpromazine and its sulfoxide.
The

Using our dye—partition scheme, the sulfoxide yields a color which is
roughly 1/5 the value given by chlorpromazine in equimolar concentrations.
Hence our dye scheme is not applicable as such to the analysis of fluids con~

taining both derivatives, unless some additional information is available on
the relative amounts present.‘ Fortunately the relative proportions can be
estimated from the extent to which the color is depressed by the addition of
ether. Nonetheless, we are withholding a manuscript dealing with chlorpromazine
analysis until this question is completely resolved.
Ultraviolet and chromatographic studies are to be undertaken soon to
establish the various chlorpromazine derivatives in urine and their clinical
significance.
2. Role of Toxic Agents in Mental Diseas

:

An Enzyme

Test for

LSD

first draft

of a manuscript entitled "Inhibition of Serum Cholinesterase
by Lysergic Acid Derivatives. Submicro Detection of LSD 25" has been completed.
Copies are to be forwarded to the Research Committee on Dec. 8th.
The

3. Steroid

Hormone Conjugates

Little progress has been made in this area in the last 6 weeks because of
a delay in construction of our chromatography cabinet and unavailability of
electrical parts needed for the circuit. This situation should be remedied by

the middle of December.
cc. to:

Dr. M. Fink
Dr. Jos. S.A. Miller

�ELECTROSHOCK THERAPY EVALUATION PROGRAM

from the

Research Service of the Hillside Hospital

Glen Oaks,

New

York

December 20, 1955

Alvin E. Coleman, President
Joseph S.A. Miller,

M. D.

Iiedical Director

�Electroshock Therapy Evaluation Program

em
I.

Aim

II. Background
III. Previous Studies
Development
and
Progress
in
Studies
IV.

Tests of Altered Brain Function
Premorbid Personality
of
Adaptation
Patterns
NonAVerbal
Verbal,
Evaluation of Improvement
Steroid Excretion Studies
Autonomic Studies
V.

Program Summary
Method

Significance

VI. Facilities Available

Laboratories
Personnel

VII. Budget
Present Budget
Requested Support

VIII. Appendix
References
Bibliography of Personnel

Page

�I.

E:
During the past few decades there has been an

of various

new somatic

intensified development

therapies for mental illness. Jhile

some have

even-

been
an
has
established
as
electroshock
therapy
into
fallen
disrepute,
tually
important and successful method for both immediate and long term results (1).

Despite

its

empirical usefulness, the

many

theories concerning the

mechanism

of this therapy have been either disproven or are so vague that their validity

tested. In a comprehensive review, Kalinowsky and Koch (2) emphasize the lack of information in this regard stating: ".......the theoretical
cannot be

aspects of the various somatic treatments
in the case of the shock treatments,

still

.....

are poorly understood, or, as

entirely obscure in their

mode

of

action."
The aim

of this program is to study the therapeutic mechanisms in electro-

convulsive therapy by the systematic investigation of behavioral, personality,

physiological and biochemical factors. Thile the program has electroconvulsive
therapy as its focus, considerable theoretical and experimental information can
be derived

to relate the

phenomena observed

in this therapy to other somatic

treatments such as lobotomy, electronarcosis and insulin coma.

�II.

BACKGROUND:

of
abundance
has
stimulated
an
electroconvulsive
therapy
of
use
and
the
Both
kind
theories
of
the
much
and
research.
exper(3)
hypotheses
The

of
interest
the
reflect
however,
particular
undertaken,
imental investigations
the
origin
frame
reference
of
regarding
and
theoretical
his
the investigator
of mental disorders.

Thus, each has been usually limited to one aspect of the

problem. In general, these theories

may be

differentiated between those that

emphasize physiological, biochemical, or psychological constructs.
A

who

classical physiological construct is exemplified

suggests that the various

by Gellhorn (h)

forms of shock therapy "act on the centers of

the autonomic system, produce intensive and prolonged sympathetico-adrenal
mental
activity,
hypothalamic-cortical
augmented
and
alter, through
discharges
processes and behavior."
psychogalvanic reflex,

The

varying responses of blood pressure, heart rate,

and other physiological indices to chemical

stresses are

obtained
been
has
data
huch
of
sympathetic reactivity.
interpreted as indices
to
and

Show

autonomic
reactivity,
in
this
induces
change
a
electroshock
therapy
that

(5)
coaworkers
and
support this
his
Funkenstein
by
studies
recent

conclusion.
Much

illness

and

biochemical study has been devoted to the relation between mental

steroid metabolism.

between ketosteroid excretion

Numerous

rates

instances (6) in which a relation

and change

in mental state following

electroshock therapy are reported, but the clinical difficulties in the
measurement of steroids have left this issue unresolved. Kore recent studies

excretion
to
the
total
steroids
between
individual
the
relationship
exploring
rate (7) utilize elaborate chromatographic separation technics.

�In a good review of the biochemical and neurophysiological hypotheses,
mode
the
view
the
that
evidence
to
justify
Ashby (8) presents experimental
of action of electroconvulsive therapy

is

through effects on the adrenal

cortex mediated by direct stimulation of the hypothysis.
Psychologic constructs generally fall into three designs

- studies

of

the psychic significance of the loss of consciousness; the relative importance of

ities

memory

loss;

and an estimate of the

subject's re-integrating abil-

the
Numerous
unemphasize
studies
of
confusion.
following a period

conscious significance of the treatment as a “rebirth which eliminates reand
exneed
punishment
for
of
a
satisfaction
narcissism"
a
(9);
or
gressed

piation for committed sins (10).
Amnesic effects are a common concomitant of treatment but most studies
of
these
The
significance
of
impairment.
the
nature
emphasize the temporary
defects for therapeutic results is

emphasized by numerous authors.

Data

is

the
on
emotional
charge
patreduces
the
treatment
that
presented to
emotionallyfor
of
induces
familiarity
loss
a
associations
(ll),
ient's
show

toned associations (12), or a selective forgetting of unpleasant

life

memories (13).
These constructs are

further elaborated by authors

who

believe that the

as
behavioral
responses
confusionalemate
including
of
an organic
induction
im»
electroshock
the
for
basis
is
over-reacting
euphoria, impulsiveness or
provement (1h).

A

more

umerated by Weinstein

&amp;

recent elaboration of this explanation is that enKahn

(15), described subsequently.

�-h-

adaptive
in
changes
proregard
explanations
of
psychologic
Another group
describe
(16)
and
Frosch
Impastato
mechanism.
cesses as the basic therapeutic
on
a
which
then
re-integrates
the
of
ego
electroshock as causing a dissolution
suggestopinion
similar
has
a
Alexander
of
adaptation.
previous or higher level

ing that

defensive
operations.
enhances
active
and
electroshock arouses

For

this

in'whii1
conditions
those
in
effective
such
is
therapy
that
he
asserts
reason
conp
in
ineffective
but
are
low
ebb, as in depressions,
such operations are at a
(17).
alerted
highly
already
ditions in which defensive operations are
most

two
in.which
Kahn
(15)
and
Another hypothesis was developed by weinstein

were
the
process
of
therapeutic
aspects

related.

They

asserted that the thera-

of
altered
milieu
of
a
creation
the
in
convulsions
lay
induced
of
action
peutic
is
of
problems
his
expression
symbolic
brain function in which the patient's
Their
them.
studies,
denying
of
form
the
explicitly
altered, particularly in

cerebral
with
with
patients
documented by an extensive neurologic experience
behavior.
in
adaptive
of
changes
a
function, amply demonstrate great variety

dys—

attention
(l9),
orientation
(18),
They describe altered patterns in language
manifestations
(21)
as
defect
of
and
awareness
(15b)
(20), sexual behavior
the
patient's
constitute
mechanisms
these
conclude
that
and
of adaptive behavior
attempt to deny his illness or

striking

and enduring in those

its

meanings.

patients

Such

who had

most
were
denial
at
attempts

habitually used the defenses

with
their
of
coping
means
a
as
and
rationalization
of verbal denial
of
indicative
these
patterns
that
problems (22). They also demonstrated

administraintravenous
the
following
interview
"denial" could be elicited in an
interview
the
clinical
manifest
in
not
when
were
they
tion of sodium amytal
(23)-*
followdenial
and
explicit
disorientation
of
* This appearance of patterns
with
associated
so
clearly
sodium
is
amytal
ing the administration of
authors
these
by
described
been
has
diffuse cerebral dysfunction, that it
test."
named
"amytal
the
been
has
This
(23).
as a test for such dysfunction

�-5of
denial
between
a
patient's
noted
direct
relationship
a
they
cere—
of
the
of
and
signs
the
electroshock
appearance
therapy
pain following
test)
of
mechanism
the
that
suggested
they
amytal
bral dysfunction (positive

Thus, when

electroshock therapy

may be

the facilitation of patterns of denial by altered

brain function (15).
and
psychophysiological
at
integrating
This hypothesis is an attempt
which
terms
in
View
it
of
the
and
As
operational
in
such,
factors.
logical
have
which
studies
base
our
theoretical
upon
a
has
provided
is stated, it

been elaborated.

�III

PREVIOUS STUDIES:

of
altered
manifestations
studies
investigating
For the past three years,
cerebral function in psychiatric patients, have been in progress at Hillside

Hospital.

In 1952, the application of the amytal

was asseSSed

(2h).

test to psychiatric subjects

Positive responses were found only

in patients

who had had

electroshock therapy or had other indications of organic brain disease.

in order to test the relationship between altered brain
referred
consecutive
patients
electroshock
to
therapy,
and
the
function
response
electroencephalograms,
with
serial
intervals
weekly
at
tested
treatment
were
for
During 1953-195h%

amytal

tests,

simultaneous

tactile

perception%%

tests,

and

tests of recall

function.
A

marked

correlation

was found between improvement

therapy and early, persistent
the electroencephalograms.

following electroshock

and severe changes in both the amytal

If

no such

tests

such changes did not appear, improvement

and

failed

correlations were manifest between improvement

to occur. In contrast,
and tests of recall function or changes in simultaneous tactile tests.

WM
TWenty—four subjects were

tested in this first study, and were classified

improved
markedly
as
psychiatrist
the
supervising
by
independently

ately

improved (6) and unimproved (7)

at the

(ll),

moder-

end of one month post-treatment.

Paralysis
Infantile
for
Foundation
National
from
the
Aided
Fellowship
a
by
*
(Dr. Fink, 1953) and Grant K—927, National Institute of Fental Health,
National Institutes of Health lQSh-Sé.

stimuli
two
simultaneous
tactile
of
the
of
perception
as Previous studies
one
localize
to
or
of
perceive
failure
demonstrated characteristic patterns
of the stimuli in patients with diffuse cerebral dysfunction (25).

�-7Of

the markedly improved patients, every one had at least one positive amytal

reaction during treatment.

Of

the

50

tests

given to

this group,

38 (765) were

positive. In contrast, of the unimproved patients, five of the seven never
showed a

positive result,

positive.

6 (13%) were

and of the

The

LS

tests administered to this

group, only

moderately improved group showed more positive re-

sponses than the unimproved patients, but

fell far short

of the

much improved

group.

In addition, there were consistent changes in language and non-verbal as-

pects of behavior indicating alterations in adaptive mechanisms in the

in interviews not employing amytal. These alterations

improved group, even
were

much

either minimally or only transiently manifest in the

unimproved group and

then only under the influence of sodium amytal.*
Concomitant studies of the electroencephalograms taken on a day pre-

ceding the amytal

first

measured

test indicate

for per~cent time

a similar
31 w wave

relationship.

The 160

records were

(delta) activity, the extent of

burst activity and the amplitude and frequency of the slowest waves present.
They were then placed in a rank serial order. Those falling in the upper third
were

labelled "high abnormality"

abnormality."

ality after

Of

the

and those in the lower

much improved

patients,

one week of treatment; 80%

after

25% showed

third as "low
a high degree abnormp

two weeks and over 90%

after three

In the unimproved patients, however, none had a high degree abnormality
record during the first three weeks and only one had such a record by the fourth

weeks.

week of

treatment.

The

records of the moderately improved patients

fell

between

these two groups.*%
* Presented at the Annual Meeting of the American Psychiatric Association,
Kay 10, 1955.

** Presented at the joint meeting of the Eastern and Southern Electroencephalographic Societies, Bethesda, September 30, 1955.

�Changes

in

memory and

learning were tested in these subjects by using

the principle of retroactive inhibition.

3-letter originally learned

By

the serial testing of recall of

words following the

interpolated learning of nonsense

syllables, patterns of decrement in learning and recall

were

elicited.

As

a

week
of treatthe
showed
to
third
impairment
the
increasing
up
patients
group,
ment, and a rapid improvement after the cessation of treatment. No relation-

ship, however, could be established between impairment and reSponse to treatment.*
The

responses of these subjects to simultaneous

tactile tests using touch

stimuli were also assessed. While an increasing impairment in the ability to
be
two
demonstrated with increasing
could
and
stimuli
the
localize
identify

treatment, no relation to improvement was noted.
however, and

in anticipation that

more meaningful

The

tests

were extremely gross,

correlation for this index

of altered brain function could be obtained, a study using threshold electrical

stimuli has been undertaken (pg. 10).
As

ent and

result of these studies, it was our conclusion that early, persistsevere changes in both the electroencephalogram and in the amytal tests

a

are a necessary, though not sufficient pre—requisite for improvement following
electroshock therapy. These observations make it possible to predict the short
term response to electroshock, and such a study was undertaken

earlier this

year (pg.ll).
Concomitant with these studies,

we

have made some preliminary observations

in patients undergoing insulin coma therapy. Recent reports of the value of
prolonged coma as the basis for improvement (26) have been confirmed in our
patients. In

one unusual case

report

we

noted a direct relationship between

* Presented before the Electroshock Research Association,1;ay 8, 1955 and
awarded

their

Annual Prize award

for excellence in research design.

�altered brain function, altered patterns of adaptation in language and behavior,

clinical

and

improvement (27).

Concurrent with these psychologic investigations, basic studies have been
done

in

in biochemistry.

1950* with an

The

initial

biochemical research laboratory was established

program of study of the

relationship between steroid

excretion patterns and states of mental illness.

studies, utilizing alumina column chromatography, demonstrated atypical
The
number
excretion
of
a
levels
in
psychotic
ketosteroid
patients.
urinary
The

of B—steroids (particularly dehydroisoandrosterone) was found to be elevated,
and the etiocholanolone was depressed (7a). The ll-ketoetiocholanolone
values appeared to be sex-dependent: male patients excreted the steroid

metabolite in normal amounts, while the several female patients studied had
markedly elevated values.
During the past year, a collaborative study was

chemical department of the Sloan-Lettering

initiated with the

Institute of

new York.

bio~

Similar

steroid excretion pattern studies were undertaken utilizing paper chromatographic technics.

In the

first

phase of the study recently completed, the

elevated excretion of ll-ketoetiocholanolone was confirmed, with a severe

reduction in the excretion of this
when

compound

prior to discharge, at a time

the patient had shown considerable improvement from her

* Supported by grants from the Dazian Foundation

illness.

for Hedical Research.

�.10...
IV. §EUDIES IN PROGRESS

1.

Relation 2f

AND

Tests

IN DEVEILEEENT:

Improvement:
Function
Brain
33
Altered
3;

altered
between
relationship
direct
Our earlier studies
this
that
however,
apparent,
is
treatment.
It
to
and
function
response
brain
and
not
only
function
brain
altered
of
indices
certain
holds
for
relationship
and
elabconfirm
to
undertaken
been
has
for others. Further study, therefore,
have shown a

methods of measuring

orate these findings, as well as to investigate
improvement.
clinical
to
related
function which are more reliably

a.

cerebral

Amytal Test and Electroencephalogram:
Amytal

tests

and electroencephalograms are done

and
second
the
and
during
subjects before,

third

in all

weeks of electroshock treat—

make
a
used
predicto
data
is
the
findings
ment. On the basis of our earlier
those
that
predicted
is
treatment.
It
to
term
short
response
the
of
tion
and
with
positive
abnormality
electroencephalographic
patients with a high degree

amytal

test findings will

be most

likely to

show improvement;

while those with

amytal
and
with
negative
abnormality
a low degree electroencephalographic

results are considered unlikely to improve.
b. Tactile Perceptual Tests:
perceptual
tactile
simultaneous
the
As described before,
was
planned
inconclusive.
It
were
of
test results in our first series patients
conditions
under
stimulation,
electrical
to repeat this study using threshold
terms
Under
controlled.
be
could
rigidly
wherein the various stimulus parameters
two
of
consisting
assembly
instrument
(M—927)
an
USPHS
grant
of an existing

dewhich
can
devised
was
oscillograph
monitored
by
an
Grass Sh-B stimulators
the
assembly,
this
Using
stimuli.
electrical
wave
independent
square
liver

stimuli applied simul-

to
perceive
their
ability
for
tested
patients are
technique
refined
this
By
applying
body.
taneously to different parts of the
two

�.11be
may
otherwise
not
apparent
function
brain
in
it is anticipated that changes
and
of
improvement
the
be
to
degree
compared
will
observations
These
elicited.

to our other test~results.

As

in the case of the electroencephalogram and

the
and
intervals
during
stated
before
at
tested
are
amytal tests, patients
course of treatment.

c.

Hemory

Tests:
imp
and
loss
of
memory
of
relation
the
Numerous theories

provement have been described.

Our own

data to date

shows no

significant re-

and
words
and
simple
nonsense
syllables
for
lationship
forselective
a
there
is
evidence
that
considerable
But
there
is
improvement.
For
memories.
and
situations
of
life
significant
getting, during treatment,
between the memory loss

a record

this purpose,
may be

is

made

of events during the preceding six months which

of emotional significance to the patient. During treatment, inquiries

records
verbatim
of
these
events,
recollection
patient's
are
and these compared to the pre-treatment reports.
made

of the

2. Relation gf’Premorbid Personality

to Duration 3;

made,

Response:

has also been apparent that the relationship between altered

It

brain function and clinical response is valid only for the short term response
When
six
followed
a
for
treatment.
weeks
several
after
to treatment, ite.,

return
a
had
showing
relapsed,
the
of
improved
several
patients
period,
of their former symptoms, and in some instances requiring further hospital-

month

ization.
thesis

To

account for the varying duration of

was advanced

that the difference

personality patterns. Specifically,

it

was

clinical response, the

hypo-

related to differences in premorbid

was suggested

that patients

who showed

would
(22)
denial
verbal
personality"
the
of
"explicit
the characteristics

likely to maintain improvement.
premorbid personality of each patient is assessed

be those more
The

an interview with family members, psychologic
and

psychiatric interviews.

by

four procedures

tests, tachistoscopic tests

-

�a. Family Interviews:
At least two close relatives are seen in independent
interviews. A standardized questionnaire has been devised to elicit characterological factors indicative of the "explicit verbal denial" personality. For
this study fifteen characteristics defined as typically present or absent in
conscious—
Such
include
items
prestige
selected.
were
of
this type
personality

and
and
to
sex
attitudes
temper
to
imagination,
criticism,
ness, sensitivity
illness. Each patient is rated on a scale of 0 to 2 for each item - the higher

score signifying a greater tendency to denial.

b. Psychologic Tests:
Each

patient is tested

on a

standard psychologic eval-

uation battery including the Rorschach and Thematic Apperception TEStS. These
adap—
defense
of
and
usual
or
types
structure
character
assessed
for
tests are

tation.

Such

tests are repeated at the termination of the treatment

program and

again prior to discharge, to obtain additional information as to changes in
behavior in the course of treatment.
-

c. Tachistoscopic Tests:

tachistoscopic study has been devised; in which pairs
of emotional and non-emotional words are flashed on a screen at 10, 20, 50,
100, and 250 millisecond periods. The patient's ability to identify the words,
A

the reaction time, and the distortions are ascertained. This pre-treatment

data is

now

being explored as to

defense patterns.

The

its ability

to clarify the patient's usual

tests are repeated at the

end of greatment and again

prior to discharge for the possibility that characteristic changes in perception
develop with altered modes of adaptation..

�-13..

d. Psychiatric Interviews:
In the course of estimating changes in behavior, patients
are seen prior to treatment, and at intervals during treatment. In a clinical
interview setting, an assessment is made of the patient's symptoms, and usual
of adaptation. Changes in symptoms, behavior, language and modes of adap-

modes

tation are noted.

By

interviews with the patient's therapist, judgment as to

the significance of such changes and

bral states can
ment

their relation to treatment, or altered cere-

be made.

On

the basis of the data in a-d above a prediction of response to

is

made.

treat-

Prior to the start of treatment the patients are classified as:

1) those unlikely to improve;
2)

those likely to improve moderately or temporarily;

3)

those likely to maintain marked and sustained improvement (for at least

six months).
During the

third

week of

treatment, (after the patients have had

ments), a second prediction of the short term response
change

is

made

7—9

treat-

according to the

in the physiological indices.

3. Altered Patterns g£.Adaptation Kanifested in‘Verbal and NonéVerbal
Behavior:

In the earlier study on the amytal test

it

had been noted

that

specific changes in language and behavior indicative of altered adaptive responses occurred in the improved patients to a significantly greater degree than

in the unimproved patients. Further experimental procedures were
necessary to clarify the nature and significance of these changes.

deemed

�alb-

a.

The

is

a highly structured interview

of the patterns of language.

made

ients

who show

language

will

in émytgl Tests:
amytal test procedure is recorded. This

Language Changes Induced

situation,
The

and systematic observations are

hypothesis tested

is that those pat-

consistent, increasing use of the following types of adaptive

be more

likely

improve:
1) The use of the second or
to

third

person. In such instances the patient reports his main trouble as "the Doctors
say I'm depressed", or state the wish that "my family should be well." 2) The

selective response to questions, as answering readily questions about date and
location but failing to answer,

illness.
tive

mumbling or using neologisms when asked about

3) The use of conditional or qualifying expressions, or the subjunc-

mood which has

the effect of vitiating the patientis committment to the

is

I feel kind of dBpressed", in w hich
"sometimes" qualifies the temporal degree of illness, and "feel" and "kind of"

statement.

An example

"sometimes

‘qualify the intensity of the illness. Committment would be indicated by
the direct, unconditional statement of "I

am

depressed". h)

or stereotyped expressions in discussing illness, as "to
or "well, in a manner of speaking..." or "I didn't keep

wheel". 5) Language

antic statements. 6)
problems.

tell

my

The use

of cliches

you the

shoulder to the

filled with nonpsequiturs, circumlocution, ornate
The use

or pedp

of humor when talking about their illness or other

7) The use of metonymy or paraphasia, as

Dr. as a "recorder". 8 )The various forms of

ulation about the main problem

truth..."

referring to the examining

explicit denial including confab-

and temporal displacement.

9) changing the sym-

bolic frame of reference in response to questions, as replying to the question,

feel?", by stating, "with my hands." 10) The use of hyperbole, as
"you're the best Dr. in the whole eastern Atlantic seaboard area."
"how do you

�.15-

State:
Confusional
the
PostaShock
b. Language Changes in
Each

orientation
for
tested
is
patient

and awareness of

treatment.
a
following
immediately
awakening
of
the
period
in
his main problem
such
At
intervals.
weekly
and
then
at
treatment
the
initial
done after
@his

is

most severe, and a

defects
are
cerebral
neurologic
the
times,
These
of
language
appear.
tive changes in the pattern

variety of

may be comparable

adap—

to the

records
are
and
the
situations,
interview
other
the
in
noted
changes
language
and
changes
language
the
later
to
both
as
indications
assessed for prognostic
the degree of improvement.
Study:
Sentence
Completion
0.
in
language
in
and
changes
A way of studying the patterns

technique.
completion
sentence
a
devised
using
been
has
fashion
a quantitative
accordstructured
been
have
which
complete,
to
sentences
to
given
The patient is
the
in
first
been
have
put
sentences
the
of
Ten
different
patterns.
ing to four
when....",
criticized
am
"I
Wish that......",
such
"I
as
unconditional,
person,
the
in
expressed
are
they
that
except
meaning
in
identical
Ten others are

etc.

sometimes
"people
as
aspect,
qualifying
or
conditional
third person and with a
the
In
reetc.
When.....,"
criticized
wish that.....", "people are usually
these
of
senten
In
indicated.
maining twenty items no person is specifically
or
occurrence
exact
an
to
refers
or
direct
is
sentence
the
tences, however,

event as "every

time....",

”when the

doctor

comes

in.....",

etc.

The remainp

"at
times....",
as
aspect,
indefinite
or
qualifying
conditional,
have
a
ten
ing
etc.
when.....",
better
"things usually seem a little
for
analyzed
not
in
sentences
The response of patients to the incomplete
rated
is
each
response
Instead,
manner.
psychologic
content in the traditional

�16

the
whether
include
ratings
for its grammatical or syntactical structure.
or
conditional,
direct
or
is
second
third
person,
or
response is in the first,
The

1h).
(page
above
described
of
language
manifests aspects
1)
assumptions:
following
the
on
This study is based
begins in

the
to
most
obviously
applicable
a manner

A

sentence which

patient (e.g.,

first

person,

adaptive
reto
elicit
likely
unconditional) creates
conditional
is
or
the
third
in
person
A sentence which is expressed
2)
sponses.
and
least
minimal
is
stress
creates
is less applicable to the patient. It
complete
used
to
The
3)
person
syntactical
likely to elicit adaptive responses.
maximum

stress

and

is

most

of
indicative
is
to
person
in
regard
indeterminate
is
whose
beginning
sentence
a
shows
less
of
the
person
first
the
use
the degree of stress experienced (e.g.,

third
second
or
the
of
the
use
defensiveness,

person shows

greater defensive—

ness).
d. Attitude Interviews:
In

this

part of the study an attempt

the
of
mechanisms
ego.
adaptive
the
tionally

Two

is

made

to define

opera—

structured interviews

followed. The attitude of the

questionnaire is
interone
In
next.
the
to
interview
from
one
examiner, however, is reversed
and
the
in
concerned,
view the examiner is empathetic, pessimistic,
minimize
to
and
tends
insensitive
non-empathetic,
he
brusque,
is
other interview
are held, in which the

the patient's

same

difficulties.

In general, the

first attitude

produces good

a
in
grossly
results
latter
the
while
rapport with these disturbed patients,
each
asked
in
are
non-communicative situation. Although the same questions

to be appropriate to the examiner‘s

attitude.

interview, the wording is altered
"YOu
must
today?",
poorly
"feeling
as
such
he
questions
asks
In one interview
worse?.“
been
getting
"has
and
it
consider your condition pretty serious?",
don't
"you
today?",
well
While in another interview he asks, "feeling pretty
consider your condition serious,

do you?" and "have you been improving?".

�.11.:

The two structured.interviews are performed

just prior to electroshock

interviews
All
are
treatment.
of
treatment and repeated following the course
of
the
patient's
1)
alteration
the
study:
in
recorded. There are two variables
The
four
attitude.
examiner's
the
in
behavior by treatment, and 2) alteration
recordings are studied for

and
changes.
language
vocal
changes,
content,

The

it
defensive mechanisms of the patient
both
out
be
carried
can
that
transactions
of
the
of
terms
range
in
ationally,
and any changes

in

can be defined, oper-

be
commmay
patient
depressed
For
a
example,
very
treatment.
and
after
before
he
whereas
interview,
empathetic
concerned,
the
in
treatment
before
unicative
jovial,
mood
is
the
when
latter
examiner's
the
in
will be unable to participate

of
one
is
treatment
to
his
response
However,
if
and
minimizing.
bantering
becomes
he
sustreatment
Following
reversed.
be
euphoria, the situation may
and
empathetic,
concerned
examiner
is
when
the
anxious
or
hostile,
picious,
Thus
the
interview.
the
optimistic
in
stressful
less
communication
is
whereas
terms,
objective
in
be
stated
the defensive system of the patient can
change

i.e.,

in

of
interpersonal
standardized
range
to
a
in terms of his reactions

uations.

in

sit-

M

h. Clinical Ratings 2: "Improvement":
changes
evaluating
of
methods
and
test
These various experimental
ratthe
psychiatric
in
significance
further
have
may
and
behavior
language

considerable
experienced
we
studies
revious
In
our
:
rovement."
"im
of
P
ing
Or,
be
guide?
the
to
relief
symptomatic
Is
our
patients.
difficulty in rating
to
recovery
Is
be
the
goal?.
to
improvement"
"social
recovery"
or
is a "social

relief?

Agreement by

symptomatic
well
as
as
of
insight
be judged by the degree
"unimproved"
and
improved"
"much
"recovered",
of
definition
the
in

psychiatrists
is not available,

investigations,
to
further
crucial
is
issue
and yet, this

We

�they
terms
as
these
of
assessing
task
further
the
undertaken
have therefore
apply to the electroshock population.
of
incapacity
and
type
the
degree
are
Central to this problem of evaluation
and
the
the
of
therapist,
the
goal
personality,
of the patient, his premorbid
capacity
events,
intercurrent
as
Other
aspects,
therapy.
to
attitudes
patient's
environmental
the
patient's
of
therapy,
suitability
of the therapist, temporal
present.
at
encompassed
not
but
are
assessment,
to
important
also
assets are
To

are
studies
evaluation
following
the
"improvement",
of
meaning
clarify the

in progress.
Evaluation:
Pre-treatment
a.
the
by
therapy
electroshock
Patients are referred for
and

resident therapist.

supervising psychiatrist
evaluation is made by the research psychiatrist.

An
Two

independent psychiatric

aspects are specifically

decompensation
of
signs
clinical
encompassed in this study:
of
sympdegree
for
and
rated
mental
status
descriptive
a
recorded
in
which are
of
the
patient‘s
estimate
2)
an
(28);
scale
tomatology on a Kalamrd rating
1) the symptoms and

operations.
defensive
usual
his
of
with
description
a
develOpment
of
ego
level
Relationship:
Therapist—Patient
the
in
Changes
b.
to
held
prior
therapist
resident
the
with
interviews
In
and
the
therapist
between
relationship
the
therapy,
electroshock
of
the onset
recomp
the
for
the
reason
on
emphasis
with
specific
explored
the patient are
and
the
patient's
treatment,
the
of
the
goals
mendation for this form of therapy,
mental
of
treatment
of
method
Since the primary

attitude to the treatment.
electroshock
for
recommendation
the
disorders at this hospital is psychotherapy,
the
between
patient
communication
that
assumption
the
with
carries
it
generally
deis
the
exploration
For
this
reason,
meaningful.
no
longer
was
and therapist
and
recommendation,
the
led
to
that
relationship
the
in
voted to those changes

�19

and
symptoms that it is
behavior
of
of
those
aspects
statement
a definitive
We
the
in
interested
also
therapist's
affect.
treatment
are
may
the
anticipated

attitude to this
may

form of treatment, and attempt to assess the

role this attitude

play in the eventual results.

of
the
the
results
theories
relating
numerous
there
are
Furthermore,
made
being
are
attempts
and
in
our
inquiries,
therapy to its punitive aspects,

to assess the significance of this factor in the outcome. During the interviews with the resident therapist and with the patient, the patient's attitude
behavior)
and
against
(both
language
defensive
operations
to the treatment, his
his
in
and
alterations
the
electroshock
represents,
the reality threat that

attitude

during the weeks of treatment are

studied. Further information regard—

of
our
the
in
course
be
ascertained
will
of
factor
this
ing the significance

control study (page 21).

c.

Follow—up Study:

Crucial to the evaluation of "improvement" is the

oppor—

treatment
of
the
period
following
various
periods
tunity to repeat evaluations at
from
hosthis
discharged
of
the
patients
follow—up
report
Recently, a four-year
between
customary
the
disparity
indicated
and
(1)
this
pital was made available
of
inthis
the
In
course
illness.
discharge ratings
at
out
carried
being
observers
is
same
the
vestigation, repeat evaluations by
As
check
a
treatment.
months
after
and
six
various times during hospitalization
and eventual course of the

and
the
physiological
of
the
personality
basis
the
on the predictions
two—week
the
for
recorded
factors studied, specific follow—up evaluations are
(long-term
months
period
and
the
result)
six
post-treatment period (short-term
made on

ther—
the
resident
of
the
to
ratings
result). These evaluations are compared
each
In
instance,
medical
director.
and
the
apist, supervising psychiatrist

and
the
of
terms
projected
formulated
in
the ratings made in this study are
and
interpersonal
language
of
behavior,
those
noted
aspects
in
actual changes

�Excretion
23 Improvement:
5. Relation of Steroid
and
their
reof
steroids
excretion
patterns
of
The studies of the
More
recently
continuing.
is
9,
on
described
page
mental
to
states,
lation
of
measurement
the
for
of
techniques
development
the
on
been
has
emphasis
colorimetric
and
*
new
separative
steroid conjugates. During the past year

sulfate
steroid
measure
to
(29)
devised
techniques have been
these
for
patterns
excretion
blood and urine. Daily urinary

compounds

in

compounds

are

and
prior
again
electroshock
of
the
course
assayed prior to treatment, during
resolve
to
is
of
this
program
The
object
selected
patients.
in
to discharge

individual
total
the
with
values
these
and
compare
bound
steroids,
the sulfate excretion
hormone
between
relationship
the
elucidating
Besides
hormone levels.
which
to
extent
the
indicate
of mental illness, such studies
and

rates

states

hormones.
steroid
of
metabolism
the
the liver (30) participates in
Electroshock
Therapy:
Results
Functions
of
on
6. Effect of Autonomic
behas
studies,
it
electroencephalographic
of
our
In the course

alterations
the
typical
fail
of
number
patients
that
a
apparent
come
to
also
fail
These
patients
treatment.
extensive
in cerebral rhythms despite
and
frequently
tactile
tests,
in the amytal tests, simultaneous
to

show

show changes

reactivity
the
studies,
these
with
Simultaneous
periods.
confusional
evince no
mecholyl
of
administration
the
to
rate
and
the
pulse
blood
of the
pressure
to
done
was
prior
too,
This,
out.
carried
been
have
"Funkenstein—test")
(the
Marked
ended.
had
treatment
of
the
course
after
immediately
treatment and
two
test
these
found
in
were
medication
this
to
variations in the responses
the
of
earlier
the
reports
way
general
a
in
followed
observations
These
periods.
between
relationship
the
of
exploration
the
undertaking
workers, but we are now
tests.
physiological
and
these
function
brain
altered
of
tests
in
the alteration
* Aided by a grant (A-6YSC)
Public Health Service.

States
United
Health,
of
from the National Institutes

�v.

THE PROJECTED PROGRAM: SUMMARY

1.

3

21 -

Method:

the
along
and
development
continuation
The projected program is a
Our
ultimate
of
this
two
report.
sections
lines indicated in the preceding
the
systematic
by
therapy
electroshock
of
mechanism
goal is to clarify the
of
behavioral,
inter-relationship
the
of
and integrated investigation
biochemical
factors.
and
physiological
sonality,
This program

is

per—

rev
interdisciplinary
full-time
a
by
undertaken
being

neurophysiolpgist,
psychoanalyst,
of
psychiatrists,
search staff consisting
help.
technical
and
allied
biochemist
physiologist, experimental psychologist,
Some

in
scope
clear
already
are
the
in
program
of the specific studies

and
new
continues
the
program
as
become
apparent
Others
will
and outline.
Two new basic
develop.
leads
promising
further
or
problems
appear
critical

decided
been
upon.
already
have
methodological aspects

date
work
to
our
in
1. Control group:0ne of the major deficiencies
starting
Accordingly,
control
group.
has been the absence of an adequate
two
into
divided
be
will
electroshock
for
referred
January 1, 1956, patients
of
conusual
course
the
receive
will
One
group
fashion.
random
a
in
groups
treatments.
sub-convulsive
be
given
vulsive therapy; the other group will
Ulett
of
study
instructive
recommendation follows the recently reported
This

et a1. (31).

In other respects the two groups will

be

treated in the

same

will
each
group
in
are
patients
who
will
The
only
person
fashion.
of
The
purpose
treatments.
the
administering
be the supervising psychiatrist
in—
of
the
effects
physiological
the
differentiate
to
is
such a control group
know which

outcome.
therapeutic
the
affecting

Some

duced convulsions from other factors
disease
process,
the
of
particular
1)
nature
the
of these factors might include
2) the

attitude

and symbolic

etc.;
depression,
involutional
or
as schizophrenia
of
a
large
attention
3)
the
special
the
patient;
to
treatment
of
the
meaning

�~22:

numbers of observers

h) the

incident to being placed

on

the treatment program;

attitude of the patient's therapist toward the patient

and toward

electroshock therapy, including the expected goals in each case; and S) the

relative effectiveness of other forms of therapy provided for these patients
in the hospital milieu. The use of a control group will also clarify the
nature of "Spontaneous recovery" and

may

aid in the understanding of

"atypical" results in the patients actually receiving convulsive therapy.
2. Insulin

Coma:

It is

planned to extend the present methods of study

to an investigation of those patients receiving insulin

coma

therapy.

�~23.-

2. Significance
This program of study has both applied and theoretical significance.

there
since
electroshock
of
therapy
use
clinical
It can lead to the improved
be
mechanism.
will
It
the
of
therapeutic
will be a greater understanding
to
who
better
improve,
will
those
patients
more
skillfully
select
to
possible
and
to
predict
the
involved
therapeutic
in
process,
factors
other
manipulate
more

accurately future management problems.
of
the
psychounderstanding
to
a
greater
however,
also
This study
leads,

pathology of mental

picture
which

illness.

Through the various methods of study a

clearer

will be obtained
meaningful criteria for

of the mechanism of defense and modes of communication

may

contribute

more

operationally accurate and

"improvement".
of
determination
the
for
diagnostic classification
techtherapeutic
other
on
throw
light
may
Finally, the investigation
and

and
obserthe
function
cerebral
in
niques. The studies of the alteration
have
signifi—
damage
and
cerebral
behavior
between
vations on the relationship
also
is
It
electrocoagulation.
and
cerebral
cance for the studies in Ibbotomy
modes
of
and
in
language
the
changes
into
here
gained
the
insights
that
likely
of
psychotherapy.
study
eventual
significant
make
an
possible
adaptation may

�VI. FACILITIES

AVAILABLE:

1. Hillside Hespital is a

200 bed

non-profit psychiatric hospital.

All admissions are voluntary, with periods of hospitalization varying from
h-lZ months. All patients are available for study.
The

hospital

was

established in 1927, for the purpose of treating

ulatory psychiatric patients.

A

amb-

residency training program.was instituted

earxy, under the supervision of an active staff of psychoanalytic psychiatrists.
In 1950 the research biochemical laboratory was established, to be followed

in

1953 by

the neurophysiological research laboratory.

In 19Sh these laboratories were combined and expanded, and a Research
Service established as a:full-time operation of the hospital.
Research Director was appointed to integrate
program.

At this time, the

staff consists

all

A

full-time

the studies into a basic

of the Director, research assis—

tants in psychiatry and psychology, biochemist and assistant biochemist,

siologist,

and

EEG

technician. In addition, a psychologist and

phyb

two chemists

are associated on a project basis.
Laboratory
Medcraft D-8,
two S-hB Grass

8

facilities include:

(a) Electroencephalographic unit with a

channel instrument; (b) Neurophysiological laboratory with

stimulators,

tachistoscopic projectors

ical laboratory with

Du Mont # 3&amp;0 R

and

feet of laboratory space

Beckman

Coleman Spectrophotometer, and

ifications of the A.E.C.

two synchronized

auxiliary electronic equipment; (c)

1000 square

the following major items:

oscillograph;

Biochemp

and equipped with

Spectrophotometer,'Warburg respirator,

radioisotope unit following the basic spec-

�£2 5..
ﬂ

2. Personnel:*

studies
Undergraduate
Research:
of
(a) Dr. Max Fink, H.D., Director
the
and
degree
New
Yorn
College
University,
of
Universitv
were undertaken at the
{e
the
attended
l9h2.
in
was
granted
of B.A. cum laude with Honors in Biology
New

l9h5.
in
graduating
of
Hedicine,
York University College

interneship he served in

School
of
the
from
he
where
graduated
U.S.
Army,
the

Military Heuropsychiatry in
Knox

After a rotating

19h7, and was Chief of the

Psychiatric Section, Fort

Station Hospital during 1947.
Formal neurologic

training

was

received at hontefiore Hospital in

York

New

Formal
psychiatric
(l9h9«1951).
Hosoital
Bellevue
Dsychiatric
and
at
(l9h8-l9h9)

and
than
(1950)
at
Hospital
Bellevue
?svchiatric
undertaken
at
training was

Hillside Hoscital (1952).
During 1951, and again

in

1953, he

and then

at

Mount

In 1952, he was
American Board of

first at

Sinai Hospital in

a research fellow of the Hational

Both periods of study were under the

Foundation for Infantile Paralysis.

ection of Ur. horris 3. Bender,

Was

ﬂew York

dir-

University College of ﬂedicine

ﬂew York.

the
by
in
l95h,
and
Psychiatry,
in
Feurology,
in
certified

‘sychiatry and Neurology.

Simultaneously he attended and gradof Psychoanalysis, Psychiatry and

Institute
1953.
In
January,
in
Physicians
for
Psychology, receiving their Certificate
Mental
of
Institute
National
the
of
June, l9Sh, he was granted a research grant

uated from the ”illiam

Alanson Fhite

Health for a 2-vear study of electroshock processes.

In September, l95h, he was

Fink
Dr.
Hillside
Hospital.
Service
at
Research
appointed Director of the

is

33, married and has one son.
_____._.__.___.___________.___.____________.._._____._______._____________.______.
38.
apaended,
page
of
is
personnel
* Bibliography

�7-20Collowing
Psvcuiatry:
in
Assistant
(b) Dr. Joseph Jaffe, h.D.,
the
attended
Jaffe
Dr.
l9hh),
(B.A.,
Columbia
College
at
studies
undergraduate
Then
19b7.
M.D.
in
his
and.was
granted
of
hedicine,
College
New vorlr. University
he
began
interneship,
rotating
a
he was elected to Alpha Omega Alpha. Followinr
resident
a
as
First
Hospital.
DelleVue
Psychiatric
the
at
of
study
three years
U.S.P.H.S.
posta
as
studies
his
he
completed
in psychiatry, then in neurology,
lender.
3.
Morris
Dr.
of
doctoral research fellow under the supervision

from
graduating
Air
Force,
States
United
the
in
he
was
1953,
From 1951, to
Air
Eitchell
the
at
Psychiatrist
Chief
He
was
ﬁedicine.
Aviation
the School of

Force Base Hospital.
prac—
the
private
been
in
has
he
service
Since discharge from the military
of
Board
American
the
by
psychiatry
in
He
certified
was
tice of psychiatry.
psychoin
candidate
been
he
a
has
Since
l9h9,
1953.
in
and
Neurology
Psychiatry
Psychiatry
Psychoanalysis,
of
Institute
'hite
Alanson
analysis at the William
the
at
Assistant
Research
been
has
a
two
years
the
and
past
for
and Psychology
in
position
present
to
his
He
was appointed
Mount Sinai Hospital of New York.

September, 1955.
Chemist:
Chief
Ph.D.,
Goldenberg,
(0) Dr. Harry

A

graduate of the

Tremaine
of
a
recipient
York
New
in
of
the
City
of
College
D.
in
”h.
his
received
Goldenberg
Dr.
Scholarship and graduated cum laude.
in
instructor
He
been
has
an
Brooklyn.
of
Institute
from
‘olytechnic
the
l9h9

l9hh, he was the

College
Brooklyn
and
at
(l9h6-h7)
biochemistry at the Dolytechnic Institute
Natthe
of
enzymology
Fellow
in
Research
he
l9h7~h9
was
a
In
(1951 to date).

ional Institute

of Health, and from 1950

the
to
chemist
he
was
a
1952,
to

methods
enzyme
studying
of
Brooklyn
Hospital
Jewish
the
at
U.S.D.H.S. project

in clinical chemistry.

�...27..

Dr. Robert L. Iahn, Ph.D., Assistant in Psychology:

(d)

After

graduation from Brooklyn College in l9h0, he undertook graduate studies at
Columbia University. These studies were interrupted by four years of service
and
School
Dsyc‘hology
went
he
Clinical
to
where
United
Army,
States
in the
On
and
overseas.
country
in
this
various
hospitals
served as psychologist in
of
Neurology
the
Department
in
Research
T’syc‘iologist
became
he
the
army
leaving

of the

Mount

of Dr.

horris

Sinai Hospital in

New

York, where he wormed under the supervision

B. Bender and Dr. E. A.

"einstein until January, 1955.

is

He

of
monograph,
the
and
co-author
is
studies,
experimental
of
numerous
the author
"Denial of Illness:
He

Symbolic and Physiological Aspects" published

received his Ph.D. from the

New

in

May, 1955.

York University School of Graduate Arts

instructor of psychology at Brooklyn and Huntto
been
he
a.consultant
has
two
two
For
the
past
fbr
years
years.
er Colleges
conducted
and
has
training proMental
of
Hygiene
New
York
Department
State
the

and Sciences in 1953, and

was an

he
been
has
1955,
a
Since
January,
mental
the
of
several
hospitals.
in
grams
member

of this

staff.

(e) Dr.

Hyman

years of military service,
received his 3.8. in
ogy

interns at

York

four
Following
Psychology:
in
Assistant
Ph.D.,
Korin,
he matriculated

l9h9, and

at College of the City of

his H.S. in 1950. During 1951-52 he

the Hount Sinai Hospital and

University.

New

was

York and

psychol-

matriculated for his Ph.D. at

New

Since June, 1953, he has been Research Assistant in Psychology

at Hillside Hospital.

He

recently completed his doctoral thesis on

"The

Effects

of ﬁlectroshock on Retroactive Inhibition," and received his Ph.D. in October,
1955.

his'L.

F.

(f) Dr. Arnold Blumberg, H.D., Internist: Dr. Blumberg received
from the University of Pennsylvania in l9h2, for studies in physiology,

and in l9h5, received his E.D. from

the

Mew

York

University College of Medicine.

continued
he
two
of
and
service,
military
years
interneship
Following a rotating
1952.
l9h8
First
from
to
Memorial
Goldwater
Hospital
at
his residency training

�-28he
completed
Fellow
Medicine,
in
then
a
as
as a resident in neuropsychiatry,
He
has
1950-1952.
Division
Research
the
his studies as a Research Fellow in

been a Fellow in

Medicine

at the

New York

University College of Medicine,

1951-Sh.
He was

is

an

certified

Internal Medicine in l95h and
of Physicians. He is the associate

by the American Board of

associate of the American

Attending Internist at Hillside

Academy

Hospital and has'been

directly responsible fa'

of
coordinator
well
as
as
Research
Service,
the physiological studies of the
the biochemical programs.
3. Function of Research Service:

the
Research
Service,
the
of
research
programs
In addition to the
with
actively
They
cooperate
functions.
staff is active in two additional
research
who
on
part-time
carrying
are
those members of the hospital staff
In such instances, aid

nature.
of
clinical
a
chiefly
projects,
the
planning
of
goals,
project
clarification
the

is given in

and design of programs, and

is needed.
and
during
in
is
progress,
program
Secondly, an active resident training
independon
an
to
opportunity
carry
an
given
is
the third year, each resident
been
have
two
service
projects
of
this
ent project. Since the development
such technical assistance as

the
include
projects
completed, and three are
testosterone
of
and
the
use
states
anxiety
in
of
reserpine
clinical evaluation
include
resident
At
projects
present,
coma
therapy.
insulin
to
adjuvant
an
as
now

active.

The completed

a
factor,
therapeutic
milieu
a
as
the
of
hospital
a study

clinical evaluation

and
clinical,
coma
therapy
insulin
for
substitute
a
of chlorpromazine as
aMbivalence.
of
measures
and
tachistoscopic
psychologic

�-29In

May, 1955,

the Research Service established

a.

liason with the Sloan-

York
of
steroid
New
out
study
to
cooperative
a
of
Institute
carry
Kettering
excretion rates in psychotic patients, with emphasis on the patterns altered

during and following electroshock thefapy.

�-30..

VII,

M

PRESENT BUDGET AND REQUESTED SUPYOR :

Budget and Present Support:
1. Present anus—“u
The following is the full budget of the Research Service

for the fiscal year l9SSmS6. The major Share of the program is supported
by the Board of Directors, supplemented by grants of the United States Public Health Service. Under Grant M—927 of the National Institute of Mental
Health, $1h,807 of direct costs and $2221 of overhead costs was granted

for the year September 1, 1955 to August 31, 1956. This grant is the second
year of a 2-year grant for neurophysiological studies including the present
Electroshock Evaluation Study.
awarded $6500

The

National Institute of Arthritis has

for the second year of a twoayear grant for biochemical studies.

�~31-

1.

w.-

'

Board of Directors

U.S.P.H.S.

15,000‘

15,000

-——-

Psychiatry*

7,200

7,200

--—

Research Assistant in
Psychology

8,000

-——-—

8,000

Research Assistant in
Psychology

5,000

-—-—-

5,000

2,520

2,520

-————

Chief Chemist

8,600

8,600

-—-—-

Assistant

Chemist

h,000

__—-

h,000

Assistant Chemist

2,800

2,800

-——-

Assistant in Chemistry

1,800

-——-

1,800

h50

-—-—

h50

3,810

2,253

1,557

1,200

1,000

200

Personnel

Director of Research

Psychiatgz:
Research Assistant in

7E0 Technician

-

Secretary

Biochemistgz:

2.

Equipment

3. Consumable supplies

h. Travel - Conferences
Total
Overhead
TOTAL

* 3/5 time to September 1956.

60,380

39,373

21,007

2,521

______

2,521

62,901

39,373

23,528

�.32..

2. Requestegjg‘udgetagr Support:
A.

include

requirements of the Electroshock Therapy Evaluation Project

The

two

two
of
other
modification
the
to
professional staff,
additions

specific allocations of equipment funds.
(1) Psychiatrist: The cooperation of an additional full time psycoma
insulin
include
of
to
the
study
the
needed
to enlarge
scope
chiatrist is

positions,

and

of
evaluations
the
in
to
assist
control
the
study;
therapy; to supervise
diange in patients

and carry out follow-up

studies.

For

this position, an-

alytic experience is essential.
(2)

Physiologist or Heurophysiologist:

Present physiological studies

of
Further
physiostudy
and
the
Internist.
Director
the
out
by
carried
are
by
full-time
a
of
studies
these
coordination
the
changes
requires
logical

physiologist,
(3)

M.D.

or Ph.D.

Equipment:

and physiology.

For

Present needs are focused in two areas

-

biochemistry

further refined studies of the steroid sulfate patterns

mechanical
and
a
Beckman.Spectrophotometer
the
attachment
for
a recording

carry out the anticipated physiological
studies modifications and attachments to the electroencephalograph are

shaker (Dubnoff) are requested.

To

suggested.
following budget is one suggested to continue the present proneeded
completo
the
of
1956
personnel
addition
the
with
July
1,
gnmn after
ment the present staff. The budget is divided into three categories, followB.

The

Research
Serthe
coordinated
in
which
divisions
are
the
three
laboratory
ing
and
five
period,
a
for
the
for
year
Estimates
listed
first
year,
are
vice.

including projected salary increments.

�M

First

1. Psvchiatqz:

a. Director
Secretary

Conferences

13

Year

Five Year Total

(20,-25,000)

20,000

112,500

(2,6-3,100)

2,600
1,200

11,220

(15,-18,000)
(15,-18,000)

15,000
15,000
9,000
5,500

82,500
82,500
52,500
35,000

1,200

3,600

. Personnel

1. Psychiatrist
2. Psychiatrist
3. Eeychologist
13.. Psychologist

c. Supplies
Subtotal

-

&amp;

(

9"12:OOO)

(5’5' 8,500)

Equipment

388,820

69,500

Psychiatry

2. Neurophysiologx:

a. Personnel
9,000
3,600

52,500
12,000

b. Equipment

1,000

1,000

c. Supplies

1,200

6,000

1. Physiologist
2. Technician

(9,-12,000)

(3 : 641-31400)

71,500

10,800

Subtotal - Neurophysiology
3. Biochemistry:

a. Personnel
Chief Chemist (9,-11,000)

9,000
6,000
0,000
1,800

36,000
25,000
11,200

b . Equipment

7,000

7,000

0. Supplies

1,500

7,500

1.
2.
3.
h.

Chemist
Chemist

issistant

Subtotal - Biochemistry

(6,-8,h00)

(bu-6,000)

(1,8—2,600)

29,300

137,700

�Total

First

-

All Programs

..

All Programs

113,600

598,020

17,0h0

89,700

130,6h0

687,720

Overhead Allowance\(15%)

TOTAL

Five Year Total

Year

C. Budget Reconciliation:

1. Salaries:

The

salary range for each item is consistent with pre-

sent positions established at the hospital, or for

new

positions, with neighbor-

for supervising psychiatrists is
$12,-15,000, with a projected revision to the stated scale in 1956.
ing

institutions. Present salary
2. Equipment:

ment expenditure

ance

range

For psychiatry, the

initial year

includes the equip-

for tape recording system (#600) and an annual

for expenses.

The

$600 allow—

physiological equipment expense (51000) is to allow

modification of present electroencephalographic equipment to
record other physiological indices.

The

expenditure for supplies includes

allowances for consumable items and the provision for the building of specialIized equipment.

In biochemistry, the

a recording attachment for the

Beckman

intiial

expenditure includes $7,200 for

spectrophotometer and 9800 for a Dubnoff

shaker.
3. Conferences:

Present budgetary items include this

of the Director or members of the

sum

for the use

staff to attend appropriate scientific

meet-

ings.
h. Overhead: Consistent with hospital policy and recent administrative
changes in other

grants, a

15%

allowance

is requested.

This amount includes

hospital allocations for Social Security coverage; and for such contingencies
in the expenses of the program as not reg iring a significant alteration in the
budget.

5. Subtotals and Total: The budget is presented in three sections,
representing natural subdivisions of the program, thereby allowing for modifications in support.

�VII.

APPENDIX

A. REFERENCES:

from
Discharged
317
Patients
of
Study
Follow-up
H.L.
RACHLIN,
2E.§i:
1.
in
Hosp.,
Hillside
press.
l?50,
J.
in
Hillside Hospital
and
other
Psychosurgery
Shock
Treatment,
2. KALINOWSKY, L.B. and HOCH, P.H.:
New
York,
Grune
Stratton,
(2nd
a
ed.),
Somatic Treatment in Psychiatry

1952.

19h8.
397,
Mil.
Surg.
$92:
Theories,
Shock
Therapy
Fifth
GORDON,
H.L.:
3.
and
Dsvchiatry,
Neurology
of
Foundations
h. GELLHORN, E.' Physiological
1953.
Minneopblis,
Hinnesota
Press,
University of
Nervous
Autonomic
H.C.:
S.a FNNKENSTEIN, D.H.,
Ment.
3
Nerv.
J.
Shock
Treatment,
System Changes Following Electric
GREENBLATT, M.

Dis.

329%.: 2109,

and

SOLOMON,

19,480

Which
PreA
Test
H.C.:
5.b FUNKENSTEIN, D.H., GREENBLATT, M.,
Schizophrenic
on
Treatment
Shock
Electric
of
dicts the Clinical Effects
1950.
889,
Am.
199:
Psychiat.
J.
Patients,
AND SOLOMON,

5.0.

Autonomic
Changes
H.C.:
SOLOMON,
and
M.,
FUNKENSTEIN, D.H.,
&amp;
Nerv.
J.
Patients,
in
Mentally
Changes
Psychologic
Paralleling
GREENBLATT,

Ment. Dis.

6.a.

11;: 1, 1951.

Ill

Exthe
and
in
HOAGLAND, H. et al: Changes in the Electroencephalogram
of
AgitTherapy
Electro-shock
Accompanying
cretion of T7-Ketosteroids
19h6.
Med.
§32h6,
Psychosom.
ated Depression,

Excretion
on
Treatment
of
Effect
B.H.:
6.b. ALTSCHULE, N.D. and
&amp;
Neurol.
Arch.
Mental
Disease,
with
Patients
in
of l7-Ketosteroids
1950.
516,
éﬁ:
Psychiat.
Cortins
of
Excretion
the
on
Convulsive
Therapy
6.c. ASHBY,‘W. 1.: Effects of
19h9.
275,
Ment.
Sci.
23:
and Ketosteroids, J.
PARKHURST,

Excretl7-Ketosteroid
the
of
Studies
Chromatographic
H.
WERBIN,
7.a.
gt El:
Hosp.,
Hillside
Normal
J.
Individuals,
and
ion Datterns of Psychotic
195,40
2011,
2:
l7~
Neutral
of
Urinary
The
Fractionation
S.
R.:
M.
STITCH,
and
REISS,
7.b.
Ment.
$99:
Sci.,
J.
Male
Schizophrenics,
Chronic
from
Ketosteroids
7011, 195,40

8.

ASHBY, W.

R.:

Mode

22: 202, 1952.

of Action of Electro-Convulsive Therapy,

J.

Ment. Sci.

�.36...

9.

Shock
Therapy,
Hypoglycemic
and
JELLIFFE, S. E.: Discussion on Insulin
1937.
200,
&amp;
2Q:
Psychiat.
Arch. Neurol.

of
Aspects
Psychologic
Certain
0n
E.
MOSSE,
9.:
and
J.A.B.
10. MILLETT,
l9hh.
226,
Med.
6:
Electroshock Therapy, Psychosom.
Shock
Electric
with
Treated
Patients
in
Functioning
Memory
ZUBIN,
J.:
lla.
l9h8.
33,
Dersonality
Therapy, J.
ll:
on
Therapy
Convulsive
Electric
of
Effect
S.E.:
BARRERA,
and
ZUBIN,
11b.
J.,
596,
l9hl.
ﬁg:
Biol.
Soc.
Exper.
Hemory, Proc.
Assoword
the
on
Performance
on
Shock
Therapy
of
:
Effects
ZEAEAN,
J.
12,
19h7.
Association,
Psychological
Eastern
the
at
Presented
ciation Test.
J.
Treatments,
Convulsive
Electric
Following
Loss
Memory
JANIS,
I.L.:
13.
191.18.

Personality

1.1: 29,

der
mit
Erfabrungen
Psychopathologische
GROBE,’W.:
and
W.
BAEYER,
von,
lha.
l9h7.
163,
Psychiat.
$12:
Elektrokrampfmethode, Arch. f.
after
Patients
Mental
on
Observations
E.
STAINBROOK,
J.:
H.
and
LOWENBACH,
lhbg
l9h2.
828,
Am.
2g:
Psychiat.
J.
Electroshock,
Post—Convulsive
of
Immediate
Description
Rorschach
STAINBROOK,
E.J.:
Ibo.
19AM.
302,
&amp;
Personality'lg:
Mental Function, Char.
Electroshock
During
Psychosis
KAHN,
and
R.L.:
LIEN,
L.,
WEIWSTFIN,
E.A.,
15a.
Am.
Psychiat.
J.
Shock
Therapy,
of
the
Theory
to
Relation
Its
Therapy:

1952.
22,
$92:

and
PhysioSymbolic
of
Illness:
Denial
KAI-1H,
R.L.:
15b. mnrsmm, F..A and
1955.
Illinois,
C.
Springfield,
Thomas,
Charles
Aspects,
logical
Ego,
the
on
Treatment
Shock
of
Effects
D.:
IMPASTATO,
and
FROSCH,
J.
16.
Psychoan. Quart. I]; 226, l9h8.

l7.
18.
19.
20.

Recent
Under
"Normal"
Person
of Electroshock on a

L.: Effect
1953.
696,
Am.
J. Psychiat. $92:
Stress,
in
(Paraphasia)
Misnaming
Non—aphasic
UEINSTEIN, E.A. and KAHN, R.L.:
1959.
72,
61:
a
Psychiat.
Neurol.
Arch.
A.M.A.
Brain
Disease,
Organic
Organic
in
Disorientation
of
Patterns
KAHN,
R.L.:
WEINSTEIN, E. A. and
1951.
21h,
&amp;
Neurol.
I:
Brain Disease, J. Neuropath. Clin.
"47.1%.: 7-iithdrawal, Inattention,
310133,
and
mms'mm, E.A., ram-I, R.L.,
1955.
235,
&amp;
IA:
Psychiat.
and Pain Asymbolia, A.M.A. Arch. Neurol.
ALEXANDER,

�-3721.

T‘JEII‘YST‘EIN,
&amp;

E.

nsychiat.

A.
_6_L_l:

and mm,
772, 1950.

D.

Neurol.
Arch.
Anosognosia,
of
L.: Syndrome
"

of
Denial
Illness,
in
Factors
Personality
R.L.:
MEN,
and
22. IEINSTEIN, E.A.
1953.
§_9_:
355,
&amp;
T.‘Ieurol.
Psychiat.
11.14.11. Arch.
23.

L.A. and LINN,

R.L., SUGABI'JIAN,
Brain
Disease,
Sodium
Organic
in
Amobarbital
of

“IEINS'I'Em, 33.11., MEN,

Am.

Use
Diagnostic
1.:

J. Psychiat.

112:

889, 1953.

21;.

Test"
"Amytal
E.A.:
H.
and
vmmsmm,
KAI-1N, R.L., PINK,
1955.
3,
Hosp.
3:
Hillside
Mental Illness, J.

in Patients with

Differential
the
in
Tests
Perceptual
NJ: Tactile
25a. DEF-HER, MB. and
1952.
21,
Hosp.,
Hillside
1:
J.
Disorders,
Psvchiatric
of
Diagnosis
Sign
8.
Diagnostic
Test
as
Face-Hand
1.1.3.:
25b. PINK, M. GREEN, M. and BINDER,
1952.
h6,
2:
Neurology,
of Organic Mental Syndrome,
ImproveClinical
and
Damage
Brain
26a. REVITCE-I, 13.: Observations on Organic
195h.
§_8_:
72,
Quart.
ment Following Protracted Insulin Coma, Psychiat.
Coma:
TreatInsulin
A
Prolonged
Case
of
M.:
26b. IC-“IALEJASSER, S. and CAPLAN,
1952.
1115,
Hosp.
1:
ment, J. Hillside
and
ClinicElectroencephalographic
26c. SHAGASS, C. and ROFSML, P."T.: Serial
&amp;
Neurol.
A.Z"T.A.
Arch.
Coma,
Insulin
Prolonged
of
Case
al Studies in a
195b,.
705,
Psychiat. 12.:
Posthypoglycemic
in
Studies
26d. TRACER, C.L. at £1: Electroencephalographic
19530
1135,
1.32%:
Dis.
l‘ient.
Coma, Jo NerV.
Parts
of
1-5.:
Reduplication
Delusional
and
N.
FINE,
27. KAHN, R. L., GRAUBTE’ET, D.
1955.
13h,
Hosp.
g:
Hillside
Coma
Therapy, J.
Insulin
After
1Jody
the
of
Scale,
Rating
the
A
Psychiatric
of
Revision
28. MALAI‘EUD, 'T. and SANDS, S.L.:
Am. J. Psychiat. _l_9_l_l: 231, ram.
Colorimetric
Quantitative
the
for
Dyes
Basic
Use
of
29. GOLDENBERG, H.:
Chemical
Society
American
Conjugates,
Sulfate
Estimation of Steroid
1955.
'Iarch
31,
200,
Abstract,
Highspeed
by
Synthesis
Sulfate
Steriod
:
T4..
REIL’IANN,
J.
and
30. GOLDEHBERG,
Chem.
Soc.
in
Am.
press.
J.
,
Liver Supernates,
Convulof
Evaluation
the
in
Matched
Groups
Use
The
of
G.
A.
313
31.:
31. ULE'IT,
195h.
128.:
138,
July,
Menn.
Clin.
Bull.
Photoshock,
Subconvulsive
and
sive
F11 K,

(31‘.

�B.

Publications of Personnel:
Dr.

N

l.

x Fink:

Subdural Hematoma Developing during Hospitalization, Amer. J.
Psychiat., 191: 381-383, 1950 (with Dr. M. Green).

2. Patterns in Perception of Simultaneous Tests of Face and Hand,
Trans. Amer. Neurol. Assoc., 22; 250, 1950 (with Drs. M.B. Bender
and

M.

...,

Green).

ibid,

Arch. Neurol.

&amp;

Psychiat., éé: 355-362, 1951.

Test as a Diagnostic Sign of Organic Mental Syndrome,
Neurology, 2: hé-58, 1952 (with Drs. M. B. Bender and M. Green).
The Face-Hand

Tactile Perceptual Tests in the Differential IJiagnosis of Psychiatric Disorders, J. Hillside Hosp., 1; 21—31, 1952 (with Dr. M. B.

Bender).
A

Clinical Evaluation of Carotid Angiography, Conf. Neurol., 13:

Exosomesthesia, or Displacement of Cutaneous Sensation into Extrapersonal Space, Trans. Amer. Neurol. Assoc., lg; 1952 (with Drs.
M. F. Shapiro and M. B. Bender).

....

ibid, Arch. Neurol.

&amp;

Psychiat., éﬁ: h8l-h90 1952.

9. Order of Dominance in Cutaneous Perception, Trans. Amer. Neurol.
Assoc. 2E3 238~h0, 1952 (with Drs. M.B. Bender and M. Green).
10. Development of Perception of Simultaneous Tactile Stimuli in
Normal Uhildren, Neurology, 2; 27-3h, 1953 (with Dr. M. B. Bender).
11.

Perception of Simultaneous Tactile Stimuli by Mentally Retarded
Adults, J. Nerv. Ment. Dis. 111; h3-h9, 1953 (with Drs. M. B.
Bender and M. Green).

l2. Spinal Fluid Findings

2: 137, 1953 (I-rit‘n Dr.

13.

Following Cerebral Angiography, Neurology,
M.

Stein).

Statistical

Study of a Psychoanalytic Hypothesis; Absence of a
Parent as a Specific Factor Determining Choice of Neurosis, J.
Hillside Hospital, a; 67-71, 1953 (with Dr. S. Tarachow).

A

Effects of Barbiturates
15: 1953 (with Drs.

on Perception, Trans. Amer.
M. B. Bender, P. Bergman and M.

Neurol. Assoc.,
Nathanson).

Homosexuality with Panic and Paranoid States (Case Report)
Hillside Hosp., _2_: 16h-9o, 1953.

J.

16. Standardization of the Face-Hand Test, Neurology a; 211-217, 195h
(with Dr. M. Green).

�.3917.

Patterns of Perceptual Organization with Simultaneous Stimuli, Arch.
Neurol. &amp; Psychiat., 12: 233-255, 195A (with Drs. M. B. Bender and

H. Green).

18. The Amytal Test in Patients with Mental Illness, J. Hillside Hospital,
g; 3-13, 1955 (with R. L. Kahn and E. A. Heinstein).

l9. Delusional Reduplication of Parts of

Body

After Insulin

Coma

Therapy,

Dr. Joseeh Jaﬁig:

1.

Perceptual Patterns During Recovery From General Anesthesia, Jour. of
Neurol. Neurosurg. &amp; Psychiat., 1%; 316-321, 195l (with M. B. Bender).

2.

Factor of Symmetry in Tests of Double Simultaneous Stimulation, Brain,
15: 167-176, 1952 (with M.B. Bender).

Dr. Rdbert Kahn:

1. Toxicity of Quinacrine (atabrine) for Central Nervous System: Experimental
&amp;
Human
Neurol.
Arch.
on
Psychiat., 5g: 28h—299, l9h6
Study
Subjects,
(with Dr. T. Lidz).
2. After-Imagery in Defective Fields of Vision, J. Neurol., Neurosurg. and
Psychiat., lg: 196-20h, l9h9 (with Dr. M. B. Bender).
3. A Hereditary Syndrome Characterized by Mirror Movements, Left Handedness and Organic Mental Defect, Trans. Am. Neurol. A., ZS? 22h—226,
1919 (with Drs. I. Freiman and L. Michaels).
Tumors and Vascular
15: 277-278, 1950 (with

h. Correlation of Clinical and EEG-Abnormalities in
Disease of the Brain, Trans. Am. Neurol. A.,
Drs. E. A. ieinstein and H. Strauss).

5.

Syndrome of Anosognosia, Arch. Neurol.
(with Dr. E. A. Heinstein).

&amp;

Psychiat., ég: 772-791, 1950

6. Patterns of Disorientation in Organic Brain Bisease, J. Neuropath.
Clin. Neurol. 1; 21h-226, 1951 (with Dr. E. A. heinstein)

&amp;

7. Nonaphasic Misnaming (Paraphasia) in Organic Brain Disease, A.M.A. Arch.
Neurol. &amp; Psychiat., él: 72-79, 1952 (with Dr. E. A. Neinstein).

8. Preoperative and Postoperative Personality Changes Accompanying Frontal
Lobe Heningioma,
B. Schlesinger).

9.

J. Nerv.

&amp;

Hent. Bis.,

llh;

h92-510, 1952 (with Dr.

Phenomena of Reduplication, A.M.A. Arch. Neurol. &amp; Psychiat.,
81h, 1952 (with Drs. E. A.'Heinstein and L. A. Sugarman).

él:

808-

�uhO-

Shock Therapy, Am. J. Psychiat.,
heinstein and L. Linn).

Its Relation to the

Theory of
222; 22-26, 1952 (with Drs. E. A.

10. IBychosis During Electroshock Therhpy:
'

Brain
Sodium")
Sodium
("Amytal
Organic
in
Amobarbital
of
Diagnostic
Disease, Am. J. Psychiat., 109: 12, 889-89h, 1953 (with Drs. E. A.
Ueinstein, L. A. Sugarman and L. Linn).
Use

Neurol.
Arch.
of
Denial
Factors
in
Illness,
Personality
Q2: 355—367, 1953 (with E. A. Heinstein, M.D.).

&amp;

Psychiat.,

Behavior Disturbances Following Cataract Extraction, Am. J. Psychiat.,
and
L.
Linn).
E.
1953
A.‘
einstein
(with
Drs.
281—289,
219}

Delusional Reduplication of Parts of the Body, Brain, 7?: h5-60, l95h
(with Drs. s. A. deinstein, s. Halitz, and J. hozanshiT:

Serial Administration of the "Amytal Test" for Brain Disease: Its Diag195h
&amp;
217-226,
Neurol.
Arch.
and
Psychiat.,
Value,
Prognostic
nostic
ll:
(with Drs. E. A. Heinstein and S. Malitz).
16. Ludic Behavior in Patients with :rain Disease, J. Hillside Hospital,
A.
Sugarman).
and
L.
B.
A.'Heinstein
l95h
(with
Drs.
98-106,
2:

17.

Test in Mental Illness, J. Hillsiﬁe Hospital.,
(with Drs. M. Fink and E. A. ﬂeinstein).

The Amytal

Q;

3-13, 1955

Amer.
"Irritative"
Lesions,
in
of
Functioning
Intellectual
Patterns
18.
PSychologist, 25 h02, l95h (with Dr. E. A. Meinstein).

19.

"Spatial inattention" in Patients with Localized Lesions of the CereN.
S.
l95h
(with
327-328,
Drs.
Psychologist, 2:
Pollack and M. B. Bender).

brum, Amer.
M.

Batteery,

20. The Adaptive Role of Behavior Accompanying Brain Disease as Exemplified
by the Phenomena of Reduplication, Amer. Peychologist, 2; h90, l95h (with
Dr. E. A. ieinstein).
21.

Denial of Illness: Symbolic and Physiological ASpects, Springfield, I11.,
Charles C. Thomas, 1955 (with Dr. E. A. ;einstein).

22.

Coma
Therapy,
Insulin
Body
After
of
of
Parts
the
Jelusional [@dnplication
M.
and
Fink).
D.
Graubert
1955
(with
lBh—lh7,
Drs.
J. Hillside Hosp., g:

and Pain Asymbolia, A.M.A. Arch. Neurol.

23. ’kithdrawal, Inattention,
Psychiat., 1h: 235—2h8, 1955 (with Drs.

s.

A.

neinstein ana'h.

H.

&amp;

Slote).

Spatial Inattention in Focal Cerebral Lesions, Brain, in press (with
Drs. C. S. Battersby,

M. B.

Bender and.M. Pollack).

�25. Autokinetic Movement in Patients with Sensory and.Motor Disturbances, J.
M.
M.
and
B.
Pollack
S.
(with
Drs.
H.
Battersby,
Exp. Psychol., in press
Bender).
26. Relation Between Altered Brain thction and Denial in Electroshock Ther&amp; Peychiat., in press (with Drs. M. Fink and
A.M.A.
Meurol.
Arch.
apy,
E. A. heinstein).
27.

Mount
Sinai
of
J.
With
Picture
Schizophrenia,
Clinical
a
Encephalitis
Hosp., a1; 1955 (with Drs. E. A. Heinstein and L. Linn).

Korin:

Dr.
.1.

The
New

Effects of Electroshock
York University, 1955.

on

Retroactive Inhibition, Ph.D. Thesis,

Dr. Hargz Goldenberg:
and
of
Amino
Acid
Esterase
Trypsin
Activities
of
the
1.
Chymotrypsin, Arch. Biochem., 22; 15h, 1950 (with V. Goldenberg).
pH Depenﬁence

2.

Several Derivatives of Acetyl-dl-phenylalanine, J.
5317, 1950 (with V. Goldenberg and A. McLaren).

Am. Chem.

Soc., lg:

3. Effect of Ultraviolet Light on the Specific Activity of Chymotrypsin
and Trypsin, J. Am. Chem. Soc., 72: 1131, 1951 (with A. D. McLaren).

h.

An

Ester
Leucine
of
Ethyl
Hydrolysis
the
Enzyme-Catalyzed
Into
Inquiry

Gold1951
V.
(with
Biochem.
110,
Acta,
Biophys.
1;
et
Chymotrypsin,
by
enberg and A. D. McLaren).

5. Report D-12, April 1, l9h6; cf. pp. 117-119, concerning 8-Hydroxyquinoline Method (Alcohol Extraction), in C.J. Rodden's "Analytical Chemistry
of the Manhattan Project", (with J. Greenspan, M. J. Sohuler, D. Taub,
and A. S. Carlson).
6. Calcification. V. Influence of Fluoride and Cyanide Ions in the Presence
and Absence of Magnesium, Proc. Soc. Exp.
A. L. Sobel).

Biol., 19:

719, 1951 (with

kaline Earths on Survival of the Calcify1952
(with A. E. Sobel).
695,
Exp.
Soc.
Proc.
g1:
Mechanism,
Biol.,
ing

7. Calcification. IX.Inf1uence of

A

8. Calcification. IV. Influence of Strontium and Magnesium Ions on Calcification in vitro, Proc. Soc. Exp. Biol., IQ: 716, 1951 (with A. E.
Sobel and A. Hanok5.

9. Calcification. XI. Studies of the Incorporation of Citrate in Calcification in vitro J. Dent. Res., 3;: L97, 19Sh (with A. E. Sobel
and E. Schmeriler).

�~h2§

Ions
and
Cyanide
Fluride
by
Inhibition
10. Calcification. XII. Cation-Linked
&amp; Hed., éé: 27S,
Biol.
Soc.
Exp.
Proc.
in B-GlycerophOSphate Medium,
l9Sh (with A. E. Sobel).

19Sh.
26:
690,
Chem.,
Anal.
Plots,

ll.

Rectification of Nonlinear Beer's

12.

Curves.
Nonlinear
Activity
of
Rectification
Biochem. &amp; Biophys., ég; 288, 195h.
Enzyme

Law

I.

Preliminary, Arch.

�Studs.“
'1

tho room.
L

01‘

91‘

the

“mum

Width.

01‘

tn:

1::

Win

A

man}:

Wm

Wtm «mum,
01’

khanm tar claatraoncophﬂampw

W!
«mum “W

studying 01-min manta].

with

WW

in brain

during tin

mmmd.
m

and

Wm M

wt yaw.

W

method.

for

YMMMW
mmmmno
at Madam ta
stimulation

mm
W
m,mmmmuhhmmmmmmmmpumm
thew. m
Wu.
Mitmun.
mental
W
«mum
int-mm:
um
M m
huts, ham

gatima or tho

hymn

dam-uni"
affect: of

inn-ms,

and

human

um

cum-a.

tannin; haloahraaanmkin

acid (mp-was) an anal:

and

In tho

mm-

5:

yaw, a

my at tho was in brain function during mmmuw mm «I
Mpmholamu. Dre WWW”. Kmmlwomm
and
the
Pink
to
Dr.
fellow
of
tha
a
«mm.
m
mum
«mm.
Mutilation tar Inna“): Win an imam to sup-mu that kbonhary work.

“W.

Ha

rm
on

with a

Main: 1.

W

1953

In

a alumni

ultimatum

immut-

In tbs

Ané’t‘tmwmu
aluminum
tantalum
tho integrator! “My an

laboratory was «unnamed

mam than math!

Wamhéin

11W brain mum.

the

1mm
ammo:
65

m
W
of
{w
with
maul
mania
111mm,
dwmatu
”mum
3W
m mm
mum to mmm mime. Mam dim, mun WI ef pain;
mwnwmmmmumwmmotmmmmm»
mtkm; with «13m (litmus-I m tuna-Id ma amtralkd with anal-put:
drugs. may ammu- m
ta m mammal mm a:
am:
1m1uuoha
During tho yaw, $5

mutton

tum-Ind.

More than half.

aw

85.1:

mm}.

hospi'alk

m-

mmr

M

m mammal «mum

at...

am

an.

an.

�4-»

mmmaohmmmmwmwmmmm ”mutate
ermg
than
thﬂu
Ina
1mm
yum,
”we“.
macaw
«:1th
at

mum.

mmmwmnmmsunmmmmumm

:Mz‘mmwmmmmnwdwumﬂoftb

W.
«ammuﬁmmnsmmmmmmmuuumma
mm m

In addition. tan

on

m

at mammalian!!-

mmmmm McMithmmmmmmngnmm_

mmammmomrmmmammmmmammm

uttkﬂhoapim.

.

wmmm, s.

A.

at .1:

The

mm, M. am PM

o:
mama: mm in
m
damn

IWtSMﬂs (Jam)

Bibltoﬂ (1953)

1953:»

m.

mm. m. tau-m, 9.5.. Ramon. n. m
mm
on Pmopum,
Mm... Jam 1953.
il'ink. K...

m
m,

M; m.

u. and Bond», 11.3.: remap-um a:

w man-11y mm:

m

mm at mm.“-

51mm mm. Stimuli

Now.
a m. nu. mam-w (Jar-u) 1953.
am.
mm,
3. m: m, m A sumac-1 away ’or a mummm mom-m,
am. swam no». 2167*?! (March) 1953.

rm,

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="3">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="3">
                <text>Research Files and Unpublished Works</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67254">
              <text>Progress and annual reports; research activities (folder title 2/2).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67255">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="67256">
              <text>mfp-03-01-001-0-003</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67257">
              <text>1955</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67258">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67259">
              <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="67260">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67261">
              <text>Letter to Fink; Somatic Therapy Research Program; Monthly report; Research Progress reports - Department of Biochemistry; Letters to Dr. Miller; Electroshock Therapy Evaluation Program; Annual Report - Department of Neurology; </text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67262">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="67263">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="80928">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="87489">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="94050">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="100611">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="3">
      <name>Research</name>
    </tag>
  </tagContainer>
</item>
